$fonr 2016 10-K

Concept	2016	2015 Q2	2015
Revenue	$2.140M	$16.88M	$2.005M
YoY Change	6.73%	-0.86%	2.1%
Cost Of Revenue	$1.254M	$9.700M	$1.882M
YoY Change	-33.36%	3.74%	76.38%
Gross Profit	$885.7K	$7.180M	$122.8K
YoY Change	621.41%	-6.51%	-86.31%
Gross Profit Margin	41.39%	42.54%	6.12%
Selling, General & Admin	$18.51M	$3.290M	$17.45M
YoY Change	6.08%	-25.4%	-6.11%
% of Gross Profit	2089.92%	45.82%	14212.19%
Research & Development	$1.632M	$700.0K	$1.812M
YoY Change	-9.96%	11.11%	2.93%
% of Gross Profit	184.25%	9.75%	1476.25%
Depreciation & Amortization	$3.297M	$870.0K	$3.544M
YoY Change	-6.97%	-6.45%	-7.14%
% of Gross Profit	372.29%	12.12%	2887.08%
Operating Expenses	$20.14M	$3.980M	$19.26M
YoY Change	4.57%	-21.03%	-5.33%
Operating Profit	-$19.26M	$3.200M	-$19.14M
YoY Change	0.62%	21.21%	-1.6%
Interest Expense	-$262.2K	-$100.0K	-$702.1K
YoY Change	-62.66%	-28.57%	-20.63%
% of Operating Profit		-3.13%
Other Income/Expense, Net	$190.6K	$400.0K	$13.00
YoY Change	1465746.15%	-180.0%	-100.27%
Pretax Income	$14.51M	$3.490M	$12.82M
YoY Change	13.19%	74.5%	16.01%
Income Tax	-$4.287M	-$2.710M	$2.613M
% Of Pretax Income	-29.55%	-77.65%	20.38%
Net Earnings	$15.72M	$6.200M	$12.91M
YoY Change	21.8%	35.31%	24.19%
Net Earnings / Revenue	734.8%	36.73%	643.92%
Basic Earnings Per Share	$2.60	$0.89	$2.13
Diluted Earnings Per Share	$2.379M	$0.86	$1.955M
COMMON SHARES
Basic Shares Outstanding	6.051M shares		6.051M shares
Diluted Shares Outstanding

Concept	2016	2015 Q2	2015
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.500M	$9.400M	$9.400M
YoY Change	-9.57%	-6.0%	-6.0%
Cash & Equivalents	$8.500M	$9.449M	$9.400M
Short-Term Investments
Other Short-Term Assets	$800.0K	$900.0K	$900.0K
YoY Change	-11.11%	-10.0%	-10.0%
Inventory	$2.100M	$2.900M	$2.900M
Prepaid Expenses
Receivables	$34.20M	$30.40M	$30.40M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$45.60M	$43.62M	$43.60M
YoY Change	4.59%	1.87%	1.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.50M	$12.90M	$12.90M
YoY Change	12.4%	-14.16%	-14.0%
Goodwill		$1.767M
YoY Change		0.0%
Intangibles		$8.950M
YoY Change		-14.83%
Long-Term Investments
YoY Change
Other Assets	$13.80M	$9.300M	$9.300M
YoY Change	48.39%	38.81%	38.81%
Total Long-Term Assets	$39.30M	$32.88M	$32.90M
YoY Change	19.45%	-3.23%	-3.24%
TOTAL ASSETS
Total Short-Term Assets	$45.60M	$43.62M	$43.60M
Total Long-Term Assets	$39.30M	$32.88M	$32.90M
Total Assets	$84.90M	$76.50M	$76.50M
YoY Change	10.98%	-0.39%	-0.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.300M	$1.782M	$1.800M
YoY Change	-27.78%	-28.19%	-28.0%
Accrued Expenses	$9.300M	$7.300M	$7.300M
YoY Change	27.4%	-1.35%	-7.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.400M	$2.500M	$2.500M
YoY Change	-4.0%	-13.79%	-13.79%
Total Short-Term Liabilities	$20.60M	$18.79M	$18.80M
YoY Change	9.57%	-10.18%	-10.05%
LONG-TERM LIABILITIES
Long-Term Debt	$2.100M	$5.700M	$5.700M
YoY Change	-63.16%	-32.94%	-32.94%
Other Long-Term Liabilities	$1.000M	$700.0K	$700.0K
YoY Change	42.86%	-22.22%	-22.22%
Total Long-Term Liabilities	$3.100M	$6.916M	$6.400M
YoY Change	-51.56%	-30.56%	-31.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.60M	$18.79M	$18.80M
Total Long-Term Liabilities	$3.100M	$6.916M	$6.400M
Total Liabilities	$32.50M	$25.71M	$38.10M
YoY Change	-14.7%	-16.76%	-26.02%
SHAREHOLDERS EQUITY
Retained Earnings		-$136.3M
YoY Change		-8.65%
Common Stock		$175.4M
YoY Change		0.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)		-$675.0K
YoY Change		-200.0%
Treasury Stock Shares
Shareholders Equity	$52.40M	$50.78M	$38.40M
YoY Change
Total Liabilities & Shareholders Equity	$84.90M	$76.49M	$76.50M
YoY Change	10.98%	-0.39%	-0.39%

Concept	2016	2015 Q2	2015
OPERATING ACTIVITIES
Net Income	$15.72M	$6.200M	$12.91M
YoY Change	21.8%	35.31%	24.19%
Depreciation, Depletion And Amortization	$3.297M	$870.0K	$3.544M
YoY Change	-6.97%	-6.45%	-7.14%
Cash From Operating Activities	$16.62M	$4.720M	$13.27M
YoY Change	25.2%	17.71%	-0.88%
INVESTING ACTIVITIES
Capital Expenditures	-$712.2K	-$40.00K	-$131.3K
YoY Change	442.4%	-85.71%	-78.85%
Acquisitions
YoY Change
Other Investing Activities	-$4.220M	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$5.049M	-$40.00K	-$270.8K
YoY Change	1764.13%	-85.71%	-67.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$12.49M	-3.070M	-$13.51M
YoY Change	-7.52%	-8.63%	28.93%
NET CHANGE
Cash From Operating Activities	$16.62M	4.720M	$13.27M
Cash From Investing Activities	-$5.049M	-40.00K	-$270.8K
Cash From Financing Activities	-$12.49M	-3.070M	-$13.51M
Net Change In Cash	-$920.5K	1.610M	-$502.9K
YoY Change	83.02%	335.14%	-124.17%
FREE CASH FLOW
Cash From Operating Activities	$16.62M	$4.720M	$13.27M
Capital Expenditures	-$712.2K	-$40.00K	-$131.3K
Free Cash Flow	$17.33M	$4.760M	$13.40M
YoY Change	29.28%	10.96%	-4.33%

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6157766	shares
CY2015Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	9448798	usd
CY2016Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	8528309	usd
CY2015Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs CostsInExcessOfBillingsOnUncompletedContractsOrPrograms	681660	usd
CY2016Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs CostsInExcessOfBillingsOnUncompletedContractsOrPrograms		usd
CY2015Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	2191849	usd
CY2016Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	2074300	usd
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	860040	usd
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	759042	usd
CY2015Q2	us-gaap	Assets Current AssetsCurrent	43620813	usd
CY2016Q2	us-gaap	Assets Current AssetsCurrent	45559573	usd
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12901195	usd
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14512706	usd
CY2015Q2	us-gaap	Other Assets OtherAssets	829505	usd
CY2016Q2	us-gaap	Other Assets OtherAssets	731451	usd
CY2015Q2	us-gaap	Assets Net AssetsNet	76492077	usd
CY2016Q2	us-gaap	Assets Net AssetsNet	84887606	usd
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1782442	usd
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1254485	usd
CY2015Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8252633	usd
CY2016Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10826793	usd
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4187401	usd
CY2016Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4678914	usd
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	18792652	usd
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	20613247	usd
CY2015Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	6915912	usd
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-120624010	usd
CY2015Q2	us-gaap	Treasury Stock Deferred Employee Stock Ownership Plan TreasuryStockDeferredEmployeeStockOwnershipPlan	-675390	usd
CY2016Q2	us-gaap	Treasury Stock Deferred Employee Stock Ownership Plan TreasuryStockDeferredEmployeeStockOwnershipPlan	-675390	usd
CY2015Q2	us-gaap	Minority Interest MinorityInterest	12390771	usd
CY2016Q2	us-gaap	Minority Interest MinorityInterest	8396575	usd
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	50783513	usd
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	45906592	usd
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	37799276	usd
CY2016Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3498052	usd
CY2015Q2	us-gaap	Liabilities Liabilities	25708564	usd
CY2016Q2	us-gaap	Liabilities Liabilities	24111299	usd
CY2015Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	175447586	usd
CY2016Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	173702335	usd
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-136348635	usd
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	60776307	usd
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	76492077	usd
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	84887606	usd
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet	73368210	usd
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	69050996	usd
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	68505477	usd
CY2016	us-gaap	Net Income Loss NetIncomeLoss	15724625	usd
CY2015	us-gaap	Net Income Loss NetIncomeLoss	12910651	usd
CY2014	us-gaap	Net Income Loss NetIncomeLoss	10396130	usd
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6050893	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6050632	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6009822	shares
CY2016	FONR	Abandoned Patents Written Off AbandonedPatentsWrittenOff	88796	usd
CY2015	FONR	Abandoned Patents Written Off AbandonedPatentsWrittenOff	413589	usd
CY2014	FONR	Abandoned Patents Written Off AbandonedPatentsWrittenOff	250523	usd
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3557507	usd
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4258147	usd
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4044002	usd
CY2016	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	681660	usd
CY2015	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	78149	usd
CY2014	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-314067	usd
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	117549	usd
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	251687	usd
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-366448	usd
CY2016	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	72718	usd
CY2015	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	67192	usd
CY2014	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	46967	usd
CY2016	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	18054	usd
CY2015	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	41125	usd
CY2014	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	131811	usd
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-712216	usd
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-131308	usd
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-620697	usd
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-113072	usd
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-139534	usd
CY2014	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-214211	usd
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5048855	usd
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-270842	usd
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-834908	usd
CY2016	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-3682519	usd
CY2015	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-2788401	usd
CY2014	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-4400128	usd
CY2016	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	7616	usd
CY2015	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	7333	usd
CY2014	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	15992	usd
CY2016	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	-5909100	usd
CY2015	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	-4627851	usd
CY2014	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	-4965770	usd
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12489003	usd
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13505013	usd
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10475006	usd
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-920489	usd
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-502938	usd
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2081009	usd
CY2016	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	2006	usd
CY2015	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	53200	usd
CY2014	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	223000	usd
CY2016	FONR	Capital Stock And Options Disclosure Textblock CapitalStockAndOptionsDisclosureTextblock	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR CORPORATION AND SUBSIDIARIES</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">JUNE 30, 2016, 2015 and 2014</font></p> <p style="margin: 0"></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE 8 - CAPITAL STOCK</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"><u>Common Stock</u></font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"><u>Class B Common Stock</u></font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class B common stock is convertible into shares of common stock on a one-for-one basis. Class B common stock has 10 votes per share. There were 146, 146 and 146 of such shares outstanding at June 30, 2016, 2015 and 2014, respectively.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">  </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"><u>Class C Common Stock</u></font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">On April 3, 1995, the stockholders ratified a proposal creating a new Class C common stock and authorized the exchange offering of three shares of Class C common stock for each share of the Company's outstanding Class B common stock. The Class C common stock has 25 votes per share, as compared to 10 votes per share for the Class B common stock and one vote per share for the common stock. The Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock. Although having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions. Class C common stock is convertible into shares of common stock on a three-for-one basis.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"><u>Class A Non-Voting Preferred Stock</u></font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">On April 3, 1995, the stockholders ratified a proposal consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the declaration of a stock dividend on the Company's common stock consisting of one share of Class A non-voting preferred stock for every five shares of common stock. The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such stock dividend approximates 313,000 shares.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The Class A non-voting preferred stock is entitled to a special dividend equal to 3-1/4% of first $10 million, 4-1/2% of next $20 million and 5-1/2% on amounts in excess of $30 million of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company's patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company's patents.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The Class A non-voting preferred stock participates on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution rights, liquidation rights and other rights and preferences (other than the voting rights).</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"><u>Stock Bonus Plans</u></font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">On April 23, 2010, the Board approved the 2010 Stock Bonus Plan. The plan entitles the Company to reserve 2,000,000 shares of common stock. On August 10, 2010, the Company filed Form S-8 to register the 2,000,000 shares. As of June 30, 2016, 953,221 shares of common stock of FONAR were available for future grant under this plan. For the years ended June 30, 2016, 2015 and 2014, 146, 5,000 and 46,708 shares were issued, respectively.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"><u>Options</u></font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The Company has stock option plans, which provide for the awarding of incentive and non-qualified stock options to employees, directors and consultants who may contribute to the success of the Company. The options granted vest either immediately or ratably over a period of time from the date of grant, typically three or four years, at a price determined by the Board of Directors or a committee of the Board of Directors, generally the fair value of the Company's common stock at the date of grant. The options must be exercised within ten years from the date of grant.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR’s 2002 Incentive Stock Option Plan (the “FONAR 2002 Plan”), adopted on July 1, 2002, is intended to qualify as an incentive stock option plan under Section 422A of the Internal Revenue Code of 1954, as amended. The FONAR 2002 Plan permits the issuance of stock options covering an aggregate of 100,000 shares of common stock of FONAR. The options have an exercise price equal to the fair market value of the underlying stock on the date the option is granted, are nontransferable, are exercisable for a period not exceeding ten years and expire upon the voluntary termination of employment. The FONAR 2002 Plan terminated on June 30, 2012. During the year ended June 30, 2014, 6,610 options expired, therefore no options remain outstanding.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR’s 2005 Incentive Stock Option Plan (the “FONAR 2005 Plan”), adopted on February 16, 2005,is intended to qualify as an incentive stock option plan under Section 422A of the Internal Revenue Code of 1954, as amended. The FONAR 2005 Plan permits the issuance of stock options covering an aggregate of 80,000 shares of common stock of FONAR. The options have an exercise price equal to the fair value of the underlying stock on the date the option is granted, are non-transferable, are exercisable for a period not exceeding ten years, and expire upon the voluntary termination of employment. The FONAR 2005 Plan terminated on February 14, 2015 and no options remain outstanding.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Stock option activity and weighted average exercise prices under these plans and grants for the years ended June 30, 2016, 2015 and 2014 was as follows:</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">Number of Options</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">Aggregate Intrinsic Value</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; font-weight: normal; font-style: normal; padding-left: 5.4pt">Outstanding, June 30, 2013</td><td style="width: 3%; font-weight: normal; font-style: normal"> </td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">6,610</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 3%; font-weight: normal; font-style: normal"> </td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">29.00</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 3%; font-weight: normal; font-style: normal"> </td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Granted</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Exercised</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Forfeited / Expired</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">(6,610</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">)</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">29.00</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"> </td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Outstanding, June 30, 2014</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Granted</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Exercised</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Forfeited / Expired</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; padding-left: 5.4pt">Outstanding, June 30, 2015</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; padding-left: 5.4pt">Outstanding, June 30, 2016</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt">Exercisable at:</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right"> </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right"> </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right"> </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">June 30, 2014</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right"> </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">June 30, 2015</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right"> </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">June 30, 2016</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right"> </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p>
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"><u>Use of Estimates</u></font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies, revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue to impact the Company's operations and the determination of contractual and other allowance estimates. Actual results could differ from those estimates.</font></p>
CY2016	us-gaap	Revenue Recognition Percentage Of Completion Method RevenueRecognitionPercentageOfCompletionMethod	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"><u>Revenue Recognition</u></font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Revenue on sales contracts for scanners, included in “product sales” in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion method in accordance with FASB ASC 605-35, “Revenue Recognition – Construction-Type and Production-Type Contracts”. The Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation take approximately three to six months.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Revenue on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Revenue from product and related (upgrades and supplies) sales is recognized upon shipment.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Revenue under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with various medical providers (the "PCs"). As of June 30, 2016, the Company has twenty one management agreements of which three are with PC’s owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR (“the Related medical practices”) and eighteen are with PC’s, which are all located in the state of New York (“the New York PC’s”), owned by two unrelated radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately $69,000 to $277,000. All fees are re-negotiable at the anniversary of the agreements and each year thereafter. Revenue under lease contracts is recognized based upon contractual agreements for the leasing of medical equipment primarily under long term contracts to various unrelated PC’s. The lease fee for the medical equipment consists of a fixed monthly fee of $2,000. All fees are re-negotiable at the anniversary of the agreements and each year thereafter.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patient fee revenue, net of contractual allowance and discounts, consist of net patient fees received from insurance companies, third party payors (including federal and state agencies under Medicare and Medicaid programs), hospitals and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments and discounts. Patient fee revenue is recorded in the period in which services are provided.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">  </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The Company’s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2016, 2015 and 2014 are summarized in the following table.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the Year Ended June 30,</font></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2016</font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2015</font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2014</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Commercial Insurance/ Managed Care</font></td><td style="width: 5%"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="width: 1%; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</font></td><td style="width: 11%; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,659,322</font></td><td style="width: 1%; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="width: 5%"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="width: 1%; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</font></td><td style="width: 11%; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,398,589</font></td><td style="width: 1%; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="width: 5%"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="width: 1%; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</font></td><td style="width: 11%; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,217,088</font></td><td style="width: 1%; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.1pt; padding-left: 8.1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,182,552</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,187,690</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,443,020</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Workers' Compensation/Personal Injury</font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,888,856</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">15,978,243</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">13,369,956</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other</font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,255,079</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,589,076</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,277,128</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patient Fee Revenue, net of contractual allowances and discounts</font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">32,985,809</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">28,153,598</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">24,307,192</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Provision for Bad Debts</font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(14,539,786</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(12,770,249</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(10,333,082</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net Patient Fee Revenue</font></td><td style="padding-bottom: 2.5pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">18,446,023</font></td><td style="padding-bottom: 2.5pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="padding-bottom: 2.5pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">15,383,349</font></td><td style="padding-bottom: 2.5pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="padding-bottom: 2.5pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">13,974,110</font></td><td style="padding-bottom: 2.5pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 12pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-size: 12pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-size: 12pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-size: 12pt; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-size: 12pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-size: 12pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-size: 12pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-size: 12pt; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-size: 12pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-size: 12pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-size: 12pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-size: 12pt; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-size: 12pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p>
CY2016	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"><u>Concentration of Credit Risk</u></font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash: The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2016, the Company had cash on deposit of approximately $5,804,000 in excess of federally insured limits of $250,000.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Related Parties: Net revenues from related parties accounted for approximately 10%, 11% and 11% of the consolidated net revenues for the years ended June 30, 2016, 2015 and 2014, respectively. Net management fee receivables from the related party medical practices accounted for approximately 12%, 12% and 12% of the consolidated accounts receivable for the years ended June 30, 2016, 2015 and 2014, respectively.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">See Note 3 regarding the Company’s concentrations in the healthcare industry.</font></p>
CY2016	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"><u>Reclassifications</u></font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Certain prior year amounts have been reclassified to conform to the current year presentation. The reclassifications did not have any effect on reported net income for any periods presented.</font></p>
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.6
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.13
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.73
CY2015Q2	us-gaap	Other Inventory Supplies OtherInventorySupplies	2043411	usd
CY2016Q2	us-gaap	Other Inventory Supplies OtherInventorySupplies	1862605	usd
CY2015Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	148438	usd
CY2016Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	211695	usd
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	31659539	usd
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	35313261	usd
CY2015Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7004847	usd
CY2016Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7004847	usd
CY2015Q2	FONR	Patents And Copyrights Less Amortization PatentsAndCopyrightsLessAmortization	4547545	usd
CY2016Q2	FONR	Patents And Copyrights Less Amortization PatentsAndCopyrightsLessAmortization	4571821	usd
CY2015Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10502232	usd
CY2016Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11757310	usd
CY2015Q2	FONR	Balance Beginning Of Year Balance_BeginningOfYear	10508843	usd
CY2014Q2	FONR	Balance Beginning Of Year Balance_BeginningOfYear	11904248	usd
CY2016Q2	FONR	Balance Beginning Of Year Balance_BeginningOfYear	8950160	usd
CY2015Q2	FONR	Amounts Capitalized Other Intangible Assets AmountsCapitalizedOtherIntangibleAssets	139534	usd
CY2014Q2	FONR	Amounts Capitalized Other Intangible Assets AmountsCapitalizedOtherIntangibleAssets	214211	usd
CY2016Q2	FONR	Amounts Capitalized Other Intangible Assets AmountsCapitalizedOtherIntangibleAssets	113072	usd
CY2015Q2	FONR	Abandon Patents Written Off AbandonPatentsWrittenOff	-413589	usd
CY2014Q2	FONR	Abandon Patents Written Off AbandonPatentsWrittenOff	-250523	usd
CY2016Q2	FONR	Abandon Patents Written Off AbandonPatentsWrittenOff	-88796	usd
CY2015Q2	FONR	Balance End Of Year Balance_EndOfYear	8950160	usd
CY2014Q2	FONR	Balance End Of Year Balance_EndOfYear	10508843	usd
CY2016Q2	FONR	Balance End Of Year Balance_EndOfYear	7719358	usd
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6610	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue
CY2016	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	360496	usd
CY2015	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	114683	usd
CY2014	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	310000	usd
CY2016	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations		usd
CY2015	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	29313	usd
CY2014	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	24093	usd
CY2015Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	6607107	usd
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	6495094	usd
CY2015Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	115346	usd
CY2016Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	962867	usd
CY2015Q2	FONR	Tax Credit Carryforward TaxCreditCarryforward	6751692	usd
CY2016Q2	FONR	Tax Credit Carryforward TaxCreditCarryforward	6770099	usd
CY2015Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	63849156	usd
CY2016Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	58344864	usd
CY2015Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-55425850	usd
CY2016Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-45302504	usd
CY2015Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8423306	usd
CY2016Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	13042360	usd
CY2015Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	-510492	usd
CY2016Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	-481779	usd
CY2015Q2	us-gaap	Deferred Tax Liabilities Gross Current DeferredTaxLiabilitiesGrossCurrent	-510492	usd
CY2016Q2	us-gaap	Deferred Tax Liabilities Gross Current DeferredTaxLiabilitiesGrossCurrent	-481779	usd
CY2015Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7912814	usd
CY2016Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	12560581	usd
CY2015Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	991603	usd
CY2016Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3188665	usd
CY2015Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	117480	usd
CY2016Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	45479	usd
CY2015Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	521149	usd
CY2016Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	545029	usd
CY2015Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2538340	usd
CY2016Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2402448	usd
CY2015Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	344060	usd
CY2016Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	384810	usd
CY2015Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	235000	usd
CY2016Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	241400	usd
CY2015Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	486011	usd
CY2016Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	1139857	usd
CY2016	us-gaap	Revenues Revenues	2140000	usd
CY2015	us-gaap	Revenues Revenues	2005000	usd
CY2014	us-gaap	Revenues Revenues	1963750	usd
CY2016	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	14355616	usd
CY2015	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	12899877	usd
CY2014	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	12302669	usd
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3297289	usd
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3544470	usd
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3817205	usd
CY2016	FONR	Compensatory Element Of Stock Issuances CompensatoryElementOfStockIssuances	2006	usd
CY2015	FONR	Compensatory Element Of Stock Issuances CompensatoryElementOfStockIssuances	53200	usd
CY2014	FONR	Compensatory Element Of Stock Issuances CompensatoryElementOfStockIssuances	223000	usd
CY2016	FONR	Identifiable Assets IdentifiableAssets	84887606	usd
CY2015	FONR	Identifiable Assets IdentifiableAssets	76492077	usd
CY2014	FONR	Identifiable Assets IdentifiableAssets	76789843	usd
CY2016	FONR	Capital Expenditures CapitalExpenditures	825288	usd
CY2015	FONR	Capital Expenditures CapitalExpenditures	270842	usd
CY2014	FONR	Capital Expenditures CapitalExpenditures	834908	usd
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1276882	usd
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1820979	usd
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1877932	usd
CY2016	us-gaap	Maintenance Revenue MaintenanceRevenue	9396736	usd
CY2015	us-gaap	Maintenance Revenue MaintenanceRevenue	9549316	usd
CY2014	us-gaap	Maintenance Revenue MaintenanceRevenue	10082631	usd
CY2016	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	32985809	usd
CY2015	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	28153598	usd
CY2014	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	24307192	usd
CY2016	us-gaap	Management Fees Revenue ManagementFeesRevenue	36633230	usd
CY2015	us-gaap	Management Fees Revenue ManagementFeesRevenue	34805627	usd
CY2014	us-gaap	Management Fees Revenue ManagementFeesRevenue	34839969	usd
CY2016	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	7505339	usd
CY2015	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	7381725	usd
CY2014	FONR	Management And Other Fees Related Medical Practices Net ManagementAndOtherFeesRelatedMedicalPracticesNet	7620835	usd
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1254328	usd
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1882230	usd
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1067120	usd
CY2016	us-gaap	Maintenance Costs MaintenanceCosts	2148143	usd
CY2015	us-gaap	Maintenance Costs MaintenanceCosts	2189373	usd
CY2014	us-gaap	Maintenance Costs MaintenanceCosts	2496985	usd
CY2016	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	25147	usd
CY2015	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	25220	usd
CY2014	FONR	Costs Related To Service And Repair Fees Related Parties CostsRelatedToServiceAndRepairFeesRelatedParties	27242	usd
CY2016	us-gaap	Service Management Costs ServiceManagementCosts	21949583	usd
CY2015	us-gaap	Service Management Costs ServiceManagementCosts	20970116	usd
CY2014	us-gaap	Service Management Costs ServiceManagementCosts	20851065	usd
CY2016	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	4074762	usd
CY2015	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	3883953	usd
CY2014	FONR	Costs Related To Management And Other Fees Related Medical Practices CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices	3744446	usd
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1631846	usd
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1812398	usd
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1760821	usd
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18509850	usd
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17448305	usd
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18584645	usd
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-201949	usd
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2475032	usd
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1806299	usd
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	59012594	usd
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	56151119	usd
CY2014	us-gaap	Costs And Expenses CostsAndExpenses	56202808	usd
CY2016	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	14355616	usd
CY2015	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	12899877	usd
CY2014	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	12302669	usd
CY2016	us-gaap	Interest Expense InterestExpense	-262193	usd
CY2015	us-gaap	Interest Expense InterestExpense	-702095	usd
CY2014	us-gaap	Interest Expense InterestExpense	-884541	usd
CY2016	us-gaap	Investment Income Net InvestmentIncomeNet	224263	usd
CY2015	us-gaap	Investment Income Net InvestmentIncomeNet	225270	usd
CY2014	us-gaap	Investment Income Net InvestmentIncomeNet	238928	usd
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14508246	usd
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12817862	usd
CY2016	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	28280	usd
CY2015	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	135592	usd
CY2014	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	95623	usd
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16617369	usd
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13272917	usd
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11048457	usd
CY2016	us-gaap	Profit Loss ProfitLoss	18795517	usd
CY2015	us-gaap	Profit Loss ProfitLoss	15430383	usd
CY2014	us-gaap	Profit Loss ProfitLoss	13396769	usd
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3070892	usd
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2519732	usd
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3000639	usd
CY2016	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	1113000	usd
CY2015	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	1200000	usd
CY2014	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	1037000	usd
CY2016	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	-14539786	usd
CY2015	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	-12770249	usd
CY2014	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	-10333082	usd
CY2016	us-gaap	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	18446023	usd
CY2015	us-gaap	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	15383349	usd
CY2014	us-gaap	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	13974110	usd
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13390923	usd
CY2016	us-gaap	Revenue Recognition Allowances RevenueRecognitionAllowances	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Revenue Recognition</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The Company’s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2016, 2015 and 2014 are summarized in the following table.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the Year Ended June 30,</font></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2016</font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2015</font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2014</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Commercial Insurance/ Managed Care</font></td><td style="width: 5%"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="width: 1%; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</font></td><td style="width: 11%; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,659,322</font></td><td style="width: 1%; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="width: 5%"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="width: 1%; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</font></td><td style="width: 11%; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,398,589</font></td><td style="width: 1%; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="width: 5%"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="width: 1%; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</font></td><td style="width: 11%; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,217,088</font></td><td style="width: 1%; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.1pt; padding-left: 8.1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,182,552</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,187,690</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,443,020</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Workers' Compensation/Personal Injury</font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,888,856</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">15,978,243</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">13,369,956</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other</font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,255,079</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,589,076</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,277,128</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patient Fee Revenue, net of contractual allowances and discounts</font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">32,985,809</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">28,153,598</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">24,307,192</font></td><td style="text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Provision for Bad Debts</font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(14,539,786</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(12,770,249</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</font></td><td style="padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(10,333,082</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net Patient Fee Revenue</font></td><td style="padding-bottom: 2.5pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">18,446,023</font></td><td style="padding-bottom: 2.5pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="padding-bottom: 2.5pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">15,383,349</font></td><td style="padding-bottom: 2.5pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="padding-bottom: 2.5pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">13,974,110</font></td><td style="padding-bottom: 2.5pt; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p>
CY2016	FONR	Export Product Sales ExportProductSales	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Export Product Sales</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:</font></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 50%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="11" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the Years Ended June 30,</font></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2016</font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2015</font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2014</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">United Arab Emirates</font></td><td style="width: 5%; font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">-%</font></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="width: 5%; font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">-%</font></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="width: 5%; font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">29.8</font></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Switzerland</font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">—  </font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2.2</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">12.4</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Canada</font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.3</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.1</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">—  </font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">England</font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">18.5</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">—  </font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">—  </font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Germany</font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">.6</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">71.9</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">—  </font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Puerto Rico</font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">.2</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">—  </font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">—  </font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Libya</font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">—  </font></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">—  </font></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.2</font></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">19.6</font></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">%</font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">74.2</font></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">%</font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">42.4</font></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">%</font></td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p>
CY2016	FONR	Export Service Revenues ExportServiceRevenues	<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Foreign Service and Repair Fees</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Foreign service and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries:</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 50%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="11" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the Years Ended June 30,</font></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2016</font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2015</font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2014</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; font-weight: normal; font-style: normal; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Spain</font></td><td style="width: 5%; font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.3</font></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">%</font></td><td style="width: 5%; font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.0</font></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">%</font></td><td style="width: 5%; font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.0</font></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Puerto Rico</font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.5</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.2</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.1</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Switzerland</font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.3</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.7</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.1</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Germany</font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.5</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.7</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.4</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">England</font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.5</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.7</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2.6</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Holland</font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">—  </font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.6</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.3</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Canada</font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.3</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.1</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.2</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Greece</font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.2</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.2</font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">—  </font></td><td style="font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Australia</font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.2</font></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.2</font></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.1</font></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; padding-left: 5.4pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">5.8</font></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">%</font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">7.4</font></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">%</font></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">8.8</font></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">%</font></td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"> </font></p>
CY2015Q2	us-gaap	Finite Lived Contractual Rights Gross FiniteLivedContractualRightsGross	4100000	usd
CY2016Q2	us-gaap	Finite Lived Contractual Rights Gross FiniteLivedContractualRightsGross	4100000	usd
CY2015Q2	FONR	Customer Relationships Intangible Asset CustomerRelationshipsIntangibleAsset	3800000	usd
CY2016Q2	FONR	Customer Relationships Intangible Asset CustomerRelationshipsIntangibleAsset	3800000	usd
CY2015Q2	FONR	Amoritization Of Other Intangible Assets AmoritizationOfOtherIntangibleAssets	-1284628	usd
CY2014Q2	FONR	Amoritization Of Other Intangible Assets AmoritizationOfOtherIntangibleAssets	-1359093	usd
CY2016Q2	FONR	Amoritization Of Other Intangible Assets AmoritizationOfOtherIntangibleAssets	-1255078	usd
CY2015Q2	us-gaap	Goodwill Goodwill	1767098	usd
CY2016Q2	us-gaap	Goodwill Goodwill	3322158	usd
CY2015Q2	us-gaap	Deferred Income Taxes And Other Liabilities Noncurrent DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent	510492	usd
CY2016Q2	us-gaap	Deferred Income Taxes And Other Liabilities Noncurrent DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent	481779	usd
CY2016	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2015	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2014	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-19501	usd
CY2016	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	8121	usd
CY2015	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	2339	usd
CY2014	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	3955	usd
CY2016	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-739074	usd
CY2015	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	11000	usd
CY2014	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	68943	usd
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-527957	usd
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-699555	usd
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-270482	usd
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1155571	usd
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	988324	usd
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	791112	usd
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	393075	usd
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3159015	usd
CY2015Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	2490146	usd
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	2447693	usd
CY2015Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	5699302	usd
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2059236	usd
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4287271	usd
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2612521	usd
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2348312	usd
CY2016	FONR	Foreign Product Sales ForeignProductSales	0.196	pure
CY2015	FONR	Foreign Product Sales ForeignProductSales	0.742	pure
CY2014	FONR	Foreign Product Sales ForeignProductSales	0.424	pure
CY2016	FONR	Foreign Service And Repair Fees ForeignServiceAndRepairFees	0.058	pure
CY2015	FONR	Foreign Service And Repair Fees ForeignServiceAndRepairFees	0.074	pure
CY2014	FONR	Foreign Service And Repair Fees ForeignServiceAndRepairFees	0.088	pure
CY2016	us-gaap	Advertising Expense AdvertisingExpense	535000	usd
CY2015	us-gaap	Advertising Expense AdvertisingExpense	894000	usd
CY2014	us-gaap	Advertising Expense AdvertisingExpense	889000	usd
CY2016	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	11077	usd
CY2015	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	9293	usd
CY2014	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	1885	usd
CY2016Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2016Q2	us-gaap	Cash Cash	5804000	usd
CY2016	FONR	Net Revenues From Related Parties As Percentage Of Consolidated Net Revenues NetRevenuesFromRelatedPartiesAsPercentageOfConsolidatedNetRevenues	0.1	pure
CY2015	FONR	Net Revenues From Related Parties As Percentage Of Consolidated Net Revenues NetRevenuesFromRelatedPartiesAsPercentageOfConsolidatedNetRevenues	0.11	pure
CY2014	FONR	Net Revenues From Related Parties As Percentage Of Consolidated Net Revenues NetRevenuesFromRelatedPartiesAsPercentageOfConsolidatedNetRevenues	0.11	pure
CY2002Q3	FONR	Fonar2002 Plan Permitted Issuances Of Stock Options Fonar2002PlanPermittedIssuancesOfStockOptions	100000	shares
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	35.00	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	35.00	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	34.00	pure
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	6.00	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	6.00	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	6.00	pure
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.20	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.20	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.90	pure
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	89.80	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-65.40	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-65.50	pure
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-48.60	pure
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-27.40	pure
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-29.20	pure
CY2016	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	3297289	usd
CY2015	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	3544470	usd
CY2014	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	3817205	usd
CY2016	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y256D
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4222000	usd
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4266000	usd
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4571000	usd
CY2016	us-gaap	Litigation Settlement Amount LitigationSettlementAmount		usd
CY2015	us-gaap	Litigation Settlement Amount LitigationSettlementAmount		usd
CY2014	us-gaap	Litigation Settlement Amount LitigationSettlementAmount	13586	usd
CY2016	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	2402000	usd
CY2016	FONR	Recorded Sales Tax Obligations Interest And Penalties RecordedSalesTaxObligationsInterestAndPenalties	2487000	usd
CY2016	dei	Entity Registrant Name EntityRegistrantName	Fonar Corporation
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0000355019
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2015Q2	FONR	Net Operating Carryforwards NetOperatingCarryforwards	49170420	usd
CY2016Q2	FONR	Net Operating Carryforwards NetOperatingCarryforwards	44011554	usd
CY2016	us-gaap	Other Income OtherIncome	-2439	usd
CY2015	us-gaap	Other Income OtherIncome	13	usd
CY2014	us-gaap	Other Income OtherIncome	-4835	usd
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive	237656	usd
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	30746	usd
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	32944	usd
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive	35416	usd
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	4506929	usd
CY2015Q2	FONR	Managment And Other Fees Receivable Related Medical Practices Net Allowances ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances	3507204	usd
CY2016Q2	FONR	Managment And Other Fees Receivable Related Medical Practices Net Allowances ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances	4063539	usd
CY2016	FONR	Net Management Fee Receivables From Related Medical Practices Of Consolidated Accounts Receivable NetManagementFeeReceivablesFromRelatedMedicalPracticesOfConsolidatedAccountsReceivable	0.12	pure
CY2015Q2	FONR	Accounts Receivable Service And Repair Fees AccountsReceivableServiceAndRepairFees	3790981	usd
CY2016Q2	FONR	Accounts Receivable Service And Repair Fees AccountsReceivableServiceAndRepairFees	4370155	usd
CY2015Q2	FONR	Medical Receivable MedicalReceivable	9082319	usd
CY2016Q2	FONR	Medical Receivable MedicalReceivable	10126397	usd
CY2015Q2	FONR	Management And Other Fees Non Related Parties ManagementAndOtherFees_NonRelatedParties	14057962	usd
CY2016Q2	FONR	Management And Other Fees Non Related Parties ManagementAndOtherFees_NonRelatedParties	15637831	usd
CY2015Q2	us-gaap	Shares Issued SharesIssued		shares
CY2014Q2	us-gaap	Shares Issued SharesIssued		shares
CY2013Q2	us-gaap	Shares Issued SharesIssued		shares
CY2016Q2	us-gaap	Shares Issued SharesIssued		shares
CY2016	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan		shares
CY2015	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan		shares
CY2014	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan		shares
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1755	usd
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	30600	usd
CY2015Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear	1861350	usd
CY2016Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear	893976	usd
CY2015Q2	FONR	Estimated Earnings EstimatedEarnings	1371093	usd
CY2016Q2	FONR	Estimated Earnings EstimatedEarnings	491476	usd
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	6610	shares
CY2015Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	1937813	usd
CY2016Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	1198739	usd
CY2010Q3	FONR	Shares Registered Under Form S8 SharesRegisteredUnderFormS8	2000000	shares
CY2011Q2	FONR	Private Placement Of Equity PrivatePlacementOfEquity	6000000	usd
CY2011Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	1125100	usd
CY2014Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	1125100	usd
CY2015Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	1125100	usd
CY2016	us-gaap	Multiemployer Plan Period Contributions MultiemployerPlanPeriodContributions	0	usd
CY2015	us-gaap	Multiemployer Plan Period Contributions MultiemployerPlanPeriodContributions	0	usd
CY2014	us-gaap	Multiemployer Plan Period Contributions MultiemployerPlanPeriodContributions	0	usd
CY2016	FONR	Average Monthly Payment For Stipulation Agreements AverageMonthlyPaymentForStipulationAgreements	15859	usd
CY2015Q2	us-gaap	Liability For Claims And Claims Adjustment Expense Disability Accident And Health LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth	510000	usd
CY2016Q2	us-gaap	Liability For Claims And Claims Adjustment Expense Disability Accident And Health LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth	392000	usd
CY2016	FONR	Stoploss Umbrella Policy With3 Rd Paryinsurer To Limit Maximum Potential Liability For Individual Claims StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims	100000	usd
CY2015Q2	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	-31495	usd
CY2015	FONR	Net Management Fee Receivables From Related Medical Practices Of Consolidated Accounts Receivable NetManagementFeeReceivablesFromRelatedMedicalPracticesOfConsolidatedAccountsReceivable	0.12	pure
CY2014	FONR	Net Management Fee Receivables From Related Medical Practices Of Consolidated Accounts Receivable NetManagementFeeReceivablesFromRelatedMedicalPracticesOfConsolidatedAccountsReceivable	0.12	pure
CY2010Q2	FONR	Shares Reserved For2010 Stock Bonus Plan SharesReservedFor2010StockBonusPlan	2000000	shares
CY2015Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	8423306	usd
CY2016Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	13042360	usd
CY2015Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8950160	usd
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7719358	usd
CY2015Q2	us-gaap	Accounts Payable Related Parties Noncurrent AccountsPayableRelatedPartiesNoncurrent	236920	usd
CY2016Q2	us-gaap	Accounts Payable Related Parties Noncurrent AccountsPayableRelatedPartiesNoncurrent	245041	usd
CY2016Q2	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	-23879	usd
CY2015Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	50783513	usd
CY2016Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	60776307	usd
CY2016	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	110000	usd
CY2015	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	110000	usd
CY2014	FONR	Service And Repair Fees Related Parties Net ServiceAndRepairFeesRelatedPartiesNet	110000	usd
CY2016	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	9418935	usd
CY2015	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	7939524	usd
CY2014	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	7670484	usd
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	190560	usd
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	394810	usd
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-608599	usd
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9448798	usd
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9951736	usd
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7870727	usd
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8528309	usd
CY2015Q2	us-gaap	Stockholders Equity Attributable To Parent Not Allowable For Net Capital StockholdersEquityAttributableToParentNotAllowableForNetCapital	38392742	usd
CY2016Q2	us-gaap	Stockholders Equity Attributable To Parent Not Allowable For Net Capital StockholdersEquityAttributableToParentNotAllowableForNetCapital	52379732	usd
CY2016	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1755	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2014	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	30600	shares
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4647767	usd
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2756517	usd
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2682405	usd
CY2016	FONR	Provision For Bad Debts ProvisionForBadDebts	-201949	usd
CY2015	FONR	Provision For Bad Debts ProvisionForBadDebts	2475032	usd
CY2014	FONR	Provision For Bad Debts ProvisionForBadDebts	1806299	usd
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-394797	usd
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths	2447693	usd
CY2016	FONR	Payments On Notes Receivable From Employee Stockholders PaymentsOnNotesReceivableFromEmployeeStockholders	7616	usd
CY2015	FONR	Payments On Notes Receivable From Employee Stockholders PaymentsOnNotesReceivableFromEmployeeStockholders	7333	usd
CY2014	FONR	Payments On Notes Receivable From Employee Stockholders PaymentsOnNotesReceivableFromEmployeeStockholders	15992	usd
CY2016	FONR	Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims	.59	pure
CY2015	FONR	Percentage Of Consolidated Net Revenue From Management Fees PercentageOfConsolidatedNetRevenueFromManagementFees	0.11	pure
CY2014	FONR	Percentage Of Consolidated Net Revenue From Management Fees PercentageOfConsolidatedNetRevenueFromManagementFees	0.11	pure
CY2015	FONR	Export Sales Of Medical Equipment ExportSalesOfMedicalEquipment	.742	pure
CY2014	FONR	Export Sales Of Medical Equipment ExportSalesOfMedicalEquipment	.424	pure
CY2016	FONR	Foreign Revenues Of Service And Repair Of Medical Equipment ForeignRevenuesOfServiceAndRepairOfMedicalEquipment	.058	pure
CY2015	FONR	Foreign Revenues Of Service And Repair Of Medical Equipment ForeignRevenuesOfServiceAndRepairOfMedicalEquipment	.074	pure
CY2015	FONR	Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims	0.54	pure
CY2014	FONR	Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims	0.5	pure
CY2016	FONR	Percentage Of Consolidated Net Revenue From Management Fees PercentageOfConsolidatedNetRevenueFromManagementFees	.1	pure
	FONR	Property Tax Abatement From Suffolk County Ida PropertyTaxAbatementFromSuffolkCountyIda	0.5	pure
	FONR	Property Tax Abatement PropertyTaxAbatement	440000	usd
CY2016	FONR	Included In Companys Accrued Expenses As Result Of Lawsuit IncludedInCompanysAccruedExpensesAsResultOfLawsuit	300000	usd
CY2015	FONR	Included In Companys Accrued Expenses As Result Of Lawsuit IncludedInCompanysAccruedExpensesAsResultOfLawsuit	300000	usd
CY2016	us-gaap	Interest Paid InterestPaid	356106	usd
CY2015	us-gaap	Interest Paid InterestPaid	516385	usd
CY2014	us-gaap	Interest Paid InterestPaid	668475	usd
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	360496	usd
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	143996	usd
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	349501	usd
CY2016	FONR	Export Sales Of Medical Equipment ExportSalesOfMedicalEquipment	.196	pure
CY2014	FONR	Foreign Revenues Of Service And Repair Of Medical Equipment ForeignRevenuesOfServiceAndRepairOfMedicalEquipment	0.088	pure

CY2016Q3

dei

Entity Common Stock Shares Outstanding

EntityCommonStockSharesOutstanding

6157766

shares

CY2015Q2

us-gaap

Cash And Cash Equivalents Fair Value Disclosure

CashAndCashEquivalentsFairValueDisclosure

9448798

usd

CY2016Q2

us-gaap

Cash And Cash Equivalents Fair Value Disclosure

CashAndCashEquivalentsFairValueDisclosure

8528309

usd

CY2015Q2

us-gaap

Costs In Excess Of Billings On Uncompleted Contracts Or Programs

CostsInExcessOfBillingsOnUncompletedContractsOrPrograms

681660

usd

CY2016Q2

us-gaap

Costs In Excess Of Billings On Uncompleted Contracts Or Programs

CostsInExcessOfBillingsOnUncompletedContractsOrPrograms

usd

CY2015Q2

us-gaap

Inventory Finished Goods And Work In Process

InventoryFinishedGoodsAndWorkInProcess

2191849

usd

CY2016Q2

us-gaap

Inventory Finished Goods And Work In Process

InventoryFinishedGoodsAndWorkInProcess

2074300

usd

CY2015Q2

us-gaap

Prepaid Expense And Other Assets Current

PrepaidExpenseAndOtherAssetsCurrent

860040

usd

CY2016Q2

us-gaap

Prepaid Expense And Other Assets Current

PrepaidExpenseAndOtherAssetsCurrent

759042

usd

CY2015Q2

us-gaap

Assets Current

AssetsCurrent

43620813

usd

CY2016Q2

us-gaap

Assets Current

AssetsCurrent

45559573

usd

CY2015Q2

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

12901195

usd

CY2016Q2

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

14512706

usd

CY2015Q2

us-gaap

Other Assets

OtherAssets

829505

usd

CY2016Q2

us-gaap

Other Assets

OtherAssets

731451

usd

CY2015Q2

us-gaap

Assets Net

AssetsNet

76492077

usd

CY2016Q2

us-gaap

Assets Net

AssetsNet

84887606

usd

CY2015Q2

us-gaap

Accounts Payable Current

AccountsPayableCurrent

1782442

usd

CY2016Q2

us-gaap

Accounts Payable Current

AccountsPayableCurrent

1254485

usd

CY2015Q2

us-gaap

Other Liabilities Current

OtherLiabilitiesCurrent

8252633

usd

CY2016Q2

us-gaap

Other Liabilities Current

OtherLiabilitiesCurrent

10826793

usd

CY2015Q2

us-gaap

Deferred Revenue Current

DeferredRevenueCurrent

4187401

usd

CY2016Q2

us-gaap

Deferred Revenue Current

DeferredRevenueCurrent

4678914

usd

CY2015Q2

us-gaap

Liabilities Current

LiabilitiesCurrent

18792652

usd

CY2016Q2

us-gaap

Liabilities Current

LiabilitiesCurrent

20613247

usd

CY2015Q2

us-gaap

Liabilities Noncurrent

LiabilitiesNoncurrent

6915912

usd

CY2016Q2

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-120624010

usd

CY2015Q2

us-gaap

Treasury Stock Deferred Employee Stock Ownership Plan

TreasuryStockDeferredEmployeeStockOwnershipPlan

-675390

usd

CY2016Q2

us-gaap

Treasury Stock Deferred Employee Stock Ownership Plan

TreasuryStockDeferredEmployeeStockOwnershipPlan

-675390

usd

CY2015Q2

us-gaap

Minority Interest

MinorityInterest

12390771

usd

CY2016Q2

us-gaap

Minority Interest

MinorityInterest

8396575

usd

CY2015Q2

us-gaap

Stockholders Equity

StockholdersEquity

50783513

usd

CY2014Q2

us-gaap

Stockholders Equity

StockholdersEquity

45906592

usd

CY2013Q2

us-gaap

Stockholders Equity

StockholdersEquity

37799276

usd

CY2016Q2

us-gaap

Liabilities Noncurrent

LiabilitiesNoncurrent

3498052

usd

CY2015Q2

us-gaap

Liabilities

25708564

usd

CY2016Q2

us-gaap

Liabilities

24111299

usd

CY2015Q2

us-gaap

Additional Paid In Capital Common Stock

AdditionalPaidInCapitalCommonStock

175447586

usd

CY2016Q2

us-gaap

Additional Paid In Capital Common Stock

AdditionalPaidInCapitalCommonStock

173702335

usd

CY2015Q2

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-136348635

usd

CY2016Q2

us-gaap

Stockholders Equity

StockholdersEquity

60776307

usd

CY2015Q2

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

76492077

usd

CY2016Q2

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

84887606

usd

CY2016

us-gaap

Sales Revenue Net

SalesRevenueNet

73368210

usd

CY2015

us-gaap

Sales Revenue Net

SalesRevenueNet

69050996

usd

CY2014

us-gaap

Sales Revenue Net

SalesRevenueNet

68505477

usd

CY2016

us-gaap

Net Income Loss

NetIncomeLoss

15724625

usd

CY2015

us-gaap

Net Income Loss

NetIncomeLoss

12910651

usd

CY2014

us-gaap

Net Income Loss

NetIncomeLoss

10396130

usd

CY2016

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

6050893

shares

CY2015

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

6050632

shares

CY2014

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

6009822

shares

CY2016

FONR

Abandoned Patents Written Off

AbandonedPatentsWrittenOff

88796

usd

CY2015

FONR

Abandoned Patents Written Off

AbandonedPatentsWrittenOff

413589

usd

CY2014

FONR

Abandoned Patents Written Off

AbandonedPatentsWrittenOff

250523

usd

CY2016

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

-3557507

usd

CY2015

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

-4258147

usd

CY2014

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

-4044002

usd

CY2016

us-gaap

Increase Decrease In Unbilled Receivables

IncreaseDecreaseInUnbilledReceivables

681660

usd

CY2015

us-gaap

Increase Decrease In Unbilled Receivables

IncreaseDecreaseInUnbilledReceivables

78149

usd

CY2014

us-gaap

Increase Decrease In Unbilled Receivables

IncreaseDecreaseInUnbilledReceivables

-314067

usd

CY2016

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

117549

usd

CY2015

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

251687

usd

CY2014

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

-366448

usd

CY2016

us-gaap

Increase Decrease In Prepaid Expense

IncreaseDecreaseInPrepaidExpense

72718

usd

CY2015

us-gaap

Increase Decrease In Prepaid Expense

IncreaseDecreaseInPrepaidExpense

67192

usd

CY2014

us-gaap

Increase Decrease In Prepaid Expense

IncreaseDecreaseInPrepaidExpense

46967

usd

CY2016

us-gaap

Increase Decrease In Other Noncurrent Assets

IncreaseDecreaseInOtherNoncurrentAssets

18054

usd

CY2015

us-gaap

Increase Decrease In Other Noncurrent Assets

IncreaseDecreaseInOtherNoncurrentAssets

41125

usd

CY2014

us-gaap

Increase Decrease In Other Noncurrent Assets

IncreaseDecreaseInOtherNoncurrentAssets

131811

usd

CY2016

us-gaap

Payments To Acquire Property Plant And Equipment

PaymentsToAcquirePropertyPlantAndEquipment

-712216

usd

CY2015

us-gaap

Payments To Acquire Property Plant And Equipment

PaymentsToAcquirePropertyPlantAndEquipment

-131308

usd

CY2014

us-gaap

Payments To Acquire Property Plant And Equipment

PaymentsToAcquirePropertyPlantAndEquipment

-620697

usd

CY2016

us-gaap

Payments To Acquire Intangible Assets

PaymentsToAcquireIntangibleAssets

-113072

usd

CY2015

us-gaap

Payments To Acquire Intangible Assets

PaymentsToAcquireIntangibleAssets

-139534

usd

CY2014

us-gaap

Payments To Acquire Intangible Assets

PaymentsToAcquireIntangibleAssets

-214211

usd

CY2016

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-5048855

usd

CY2015

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-270842

usd

CY2014

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-834908

usd

CY2016

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

-3682519

usd

CY2015

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

-2788401

usd

CY2014

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

-4400128

usd

CY2016

us-gaap

Repayments Of Other Debt

RepaymentsOfOtherDebt

7616

usd

CY2015

us-gaap

Repayments Of Other Debt

RepaymentsOfOtherDebt

7333

usd

CY2014

us-gaap

Repayments Of Other Debt

RepaymentsOfOtherDebt

15992

usd

CY2016

us-gaap

Payments Of Dividends Minority Interest

PaymentsOfDividendsMinorityInterest

-5909100

usd

CY2015

us-gaap

Payments Of Dividends Minority Interest

PaymentsOfDividendsMinorityInterest

-4627851

usd

CY2014

us-gaap

Payments Of Dividends Minority Interest

PaymentsOfDividendsMinorityInterest

-4965770

usd

CY2016

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-12489003

usd

CY2015

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-13505013

usd

CY2014

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-10475006

usd

CY2016

us-gaap

Cash And Cash Equivalents Period Increase Decrease

CashAndCashEquivalentsPeriodIncreaseDecrease

-920489

usd

CY2015

us-gaap

Cash And Cash Equivalents Period Increase Decrease

CashAndCashEquivalentsPeriodIncreaseDecrease

-502938

usd

CY2014

us-gaap

Cash And Cash Equivalents Period Increase Decrease

CashAndCashEquivalentsPeriodIncreaseDecrease

2081009

usd

CY2016

us-gaap

Stock Issued During Period Value Employee Benefit Plan

StockIssuedDuringPeriodValueEmployeeBenefitPlan

2006

usd

CY2015

us-gaap

Stock Issued During Period Value Employee Benefit Plan

StockIssuedDuringPeriodValueEmployeeBenefitPlan

53200

usd

CY2014

us-gaap

Stock Issued During Period Value Employee Benefit Plan

StockIssuedDuringPeriodValueEmployeeBenefitPlan

223000

usd

CY2016

FONR

Capital Stock And Options Disclosure Textblock

CapitalStockAndOptionsDisclosureTextblock

FONAR CORPORATION AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2016, 2015 and 2014   NOTE 8 - CAPITAL STOCK   Common Stock   Cash dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.   Class B Common Stock   Class B common stock is convertible into shares of common stock on a one-for-one basis. Class B common stock has 10 votes per share. There were 146, 146 and 146 of such shares outstanding at June 30, 2016, 2015 and 2014, respectively.    Class C Common Stock   On April 3, 1995, the stockholders ratified a proposal creating a new Class C common stock and authorized the exchange offering of three shares of Class C common stock for each share of the Company's outstanding Class B common stock. The Class C common stock has 25 votes per share, as compared to 10 votes per share for the Class B common stock and one vote per share for the common stock. The Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock. Although having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions. Class C common stock is convertible into shares of common stock on a three-for-one basis.   Class A Non-Voting Preferred Stock   On April 3, 1995, the stockholders ratified a proposal consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the declaration of a stock dividend on the Company's common stock consisting of one share of Class A non-voting preferred stock for every five shares of common stock. The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such stock dividend approximates 313,000 shares.   The Class A non-voting preferred stock is entitled to a special dividend equal to 3-1/4% of first $10 million, 4-1/2% of next $20 million and 5-1/2% on amounts in excess of $30 million of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company's patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company's patents.   The Class A non-voting preferred stock participates on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution rights, liquidation rights and other rights and preferences (other than the voting rights).   Stock Bonus Plans   On April 23, 2010, the Board approved the 2010 Stock Bonus Plan. The plan entitles the Company to reserve 2,000,000 shares of common stock. On August 10, 2010, the Company filed Form S-8 to register the 2,000,000 shares. As of June 30, 2016, 953,221 shares of common stock of FONAR were available for future grant under this plan. For the years ended June 30, 2016, 2015 and 2014, 146, 5,000 and 46,708 shares were issued, respectively.   Options   The Company has stock option plans, which provide for the awarding of incentive and non-qualified stock options to employees, directors and consultants who may contribute to the success of the Company. The options granted vest either immediately or ratably over a period of time from the date of grant, typically three or four years, at a price determined by the Board of Directors or a committee of the Board of Directors, generally the fair value of the Company's common stock at the date of grant. The options must be exercised within ten years from the date of grant.   FONAR’s 2002 Incentive Stock Option Plan (the “FONAR 2002 Plan”), adopted on July 1, 2002, is intended to qualify as an incentive stock option plan under Section 422A of the Internal Revenue Code of 1954, as amended. The FONAR 2002 Plan permits the issuance of stock options covering an aggregate of 100,000 shares of common stock of FONAR. The options have an exercise price equal to the fair market value of the underlying stock on the date the option is granted, are nontransferable, are exercisable for a period not exceeding ten years and expire upon the voluntary termination of employment. The FONAR 2002 Plan terminated on June 30, 2012. During the year ended June 30, 2014, 6,610 options expired, therefore no options remain outstanding.   FONAR’s 2005 Incentive Stock Option Plan (the “FONAR 2005 Plan”), adopted on February 16, 2005,is intended to qualify as an incentive stock option plan under Section 422A of the Internal Revenue Code of 1954, as amended. The FONAR 2005 Plan permits the issuance of stock options covering an aggregate of 80,000 shares of common stock of FONAR. The options have an exercise price equal to the fair value of the underlying stock on the date the option is granted, are non-transferable, are exercisable for a period not exceeding ten years, and expire upon the voluntary termination of employment. The FONAR 2005 Plan terminated on February 14, 2015 and no options remain outstanding.   Stock option activity and weighted average exercise prices under these plans and grants for the years ended June 30, 2016, 2015 and 2014 was as follows:   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">Number of Options</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">Weighted Average Exercise Price</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">Aggregate Intrinsic Value</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; font-weight: normal; font-style: normal; padding-left: 5.4pt">Outstanding, June 30, 2013</td><td style="width: 3%; font-weight: normal; font-style: normal"> </td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">6,610</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 3%; font-weight: normal; font-style: normal"> </td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">29.00</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 3%; font-weight: normal; font-style: normal"> </td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Granted</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Exercised</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Forfeited / Expired</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">(6,610</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">)</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">29.00</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"> </td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Outstanding, June 30, 2014</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Granted</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Exercised</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Forfeited / Expired</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; padding-left: 5.4pt">Outstanding, June 30, 2015</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; padding-left: 5.4pt">Outstanding, June 30, 2016</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt">Exercisable at:</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right"> </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right"> </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right"> </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">June 30, 2014</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right"> </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">June 30, 2015</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right"> </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">June 30, 2016</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right"> </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> </table>

CY2016

us-gaap

Use Of Estimates

UseOfEstimates

Use of Estimates   The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies, revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue to impact the Company's operations and the determination of contractual and other allowance estimates. Actual results could differ from those estimates.

CY2016

us-gaap

Revenue Recognition Percentage Of Completion Method

RevenueRecognitionPercentageOfCompletionMethod

Revenue Recognition   Revenue on sales contracts for scanners, included in “product sales” in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion method in accordance with FASB ASC 605-35, “Revenue Recognition – Construction-Type and Production-Type Contracts”. The Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation take approximately three to six months.   Revenue on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.   Revenue from product and related (upgrades and supplies) sales is recognized upon shipment.   Revenue under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with various medical providers (the "PCs"). As of June 30, 2016, the Company has twenty one management agreements of which three are with PC’s owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR (“the Related medical practices”) and eighteen are with PC’s, which are all located in the state of New York (“the New York PC’s”), owned by two unrelated radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately $69,000 to $277,000. All fees are re-negotiable at the anniversary of the agreements and each year thereafter. Revenue under lease contracts is recognized based upon contractual agreements for the leasing of medical equipment primarily under long term contracts to various unrelated PC’s. The lease fee for the medical equipment consists of a fixed monthly fee of $2,000. All fees are re-negotiable at the anniversary of the agreements and each year thereafter.   Patient fee revenue, net of contractual allowance and discounts, consist of net patient fees received from insurance companies, third party payors (including federal and state agencies under Medicare and Medicaid programs), hospitals and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments and discounts. Patient fee revenue is recorded in the period in which services are provided.    The Company’s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2016, 2015 and 2014 are summarized in the following table.   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid">For the Year Ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2016</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2014</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Commercial Insurance/ Managed Care</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,659,322</td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,398,589</td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,217,088</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.1pt; padding-left: 8.1pt">Medicare/Medicaid</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,182,552</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,187,690</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,443,020</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Workers' Compensation/Personal Injury</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,888,856</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,978,243</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,369,956</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,255,079</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,589,076</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,277,128</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Patient Fee Revenue, net of contractual allowances and discounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32,985,809</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,153,598</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,307,192</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt">Provision for Bad Debts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(14,539,786</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(12,770,249</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,333,082</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Net Patient Fee Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18,446,023</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,383,349</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,974,110</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 12pt"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td></tr> </table>

CY2016

us-gaap

Concentration Risk Credit Risk

ConcentrationRiskCreditRisk

Concentration of Credit Risk   Cash: The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2016, the Company had cash on deposit of approximately $5,804,000 in excess of federally insured limits of $250,000.   Related Parties: Net revenues from related parties accounted for approximately 10%, 11% and 11% of the consolidated net revenues for the years ended June 30, 2016, 2015 and 2014, respectively. Net management fee receivables from the related party medical practices accounted for approximately 12%, 12% and 12% of the consolidated accounts receivable for the years ended June 30, 2016, 2015 and 2014, respectively.   See Note 3 regarding the Company’s concentrations in the healthcare industry.

CY2016

us-gaap

Prior Period Reclassification Adjustment Description

PriorPeriodReclassificationAdjustmentDescription

Reclassifications   Certain prior year amounts have been reclassified to conform to the current year presentation. The reclassifications did not have any effect on reported net income for any periods presented.

CY2016

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

2.6

CY2015

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

2.13

CY2014

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.73

CY2015Q2

us-gaap

Other Inventory Supplies

OtherInventorySupplies

2043411

usd

CY2016Q2

us-gaap

Other Inventory Supplies

OtherInventorySupplies

1862605

usd

CY2015Q2

us-gaap

Inventory Work In Process

InventoryWorkInProcess

148438

usd

CY2016Q2

us-gaap

Inventory Work In Process

InventoryWorkInProcess

211695

usd

CY2015Q2

us-gaap

Property Plant And Equipment Gross

PropertyPlantAndEquipmentGross

31659539

usd

CY2016Q2

us-gaap

Property Plant And Equipment Gross

PropertyPlantAndEquipmentGross

35313261

usd

CY2015Q2

us-gaap

Capitalized Computer Software Net

CapitalizedComputerSoftwareNet

7004847

usd

CY2016Q2

us-gaap

Capitalized Computer Software Net

CapitalizedComputerSoftwareNet

7004847

usd

CY2015Q2

FONR

Patents And Copyrights Less Amortization

PatentsAndCopyrightsLessAmortization

4547545

usd

CY2016Q2

FONR

Patents And Copyrights Less Amortization

PatentsAndCopyrightsLessAmortization

4571821

usd

CY2015Q2

us-gaap

Finite Lived Intangible Assets Accumulated Amortization

FiniteLivedIntangibleAssetsAccumulatedAmortization

10502232

usd

CY2016Q2

us-gaap

Finite Lived Intangible Assets Accumulated Amortization

FiniteLivedIntangibleAssetsAccumulatedAmortization

11757310

usd

CY2015Q2

FONR

Balance Beginning Of Year

Balance_BeginningOfYear

10508843

usd

CY2014Q2

FONR

Balance Beginning Of Year

Balance_BeginningOfYear

11904248

usd

CY2016Q2

FONR

Balance Beginning Of Year

Balance_BeginningOfYear

8950160

usd

CY2015Q2

FONR

Amounts Capitalized Other Intangible Assets

AmountsCapitalizedOtherIntangibleAssets

139534

usd

CY2014Q2

FONR

Amounts Capitalized Other Intangible Assets

AmountsCapitalizedOtherIntangibleAssets

214211

usd

CY2016Q2

FONR

Amounts Capitalized Other Intangible Assets

AmountsCapitalizedOtherIntangibleAssets

113072

usd

CY2015Q2

FONR

Abandon Patents Written Off

AbandonPatentsWrittenOff

-413589

usd

CY2014Q2

FONR

Abandon Patents Written Off

AbandonPatentsWrittenOff

-250523

usd

CY2016Q2

FONR

Abandon Patents Written Off

AbandonPatentsWrittenOff

-88796

usd

CY2015Q2

FONR

Balance End Of Year

Balance_EndOfYear

8950160

usd

CY2014Q2

FONR

Balance End Of Year

Balance_EndOfYear

10508843

usd

CY2016Q2

FONR

Balance End Of Year

Balance_EndOfYear

7719358

usd

CY2015Q2

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

shares

CY2014Q2

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

shares

CY2013Q2

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

6610

shares

CY2016Q2

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

shares

CY2016

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

shares

CY2015

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

shares

CY2014

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

shares

CY2015Q2

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

CY2014Q2

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

CY2013Q2

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

29

CY2016Q2

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

CY2016

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

CY2015

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

CY2014

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

CY2016

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice

CY2015

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice

CY2014

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice

CY2015Q2

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue

CY2014Q2

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue

CY2013Q2

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue

CY2016

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue

CY2015

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue

CY2014

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue

CY2016

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue

CY2015

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue

CY2014

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue

CY2016

us-gaap

Federal Income Tax Expense Benefit Continuing Operations

FederalIncomeTaxExpenseBenefitContinuingOperations

360496

usd

CY2015

us-gaap

Federal Income Tax Expense Benefit Continuing Operations

FederalIncomeTaxExpenseBenefitContinuingOperations

114683

usd

CY2014

us-gaap

Federal Income Tax Expense Benefit Continuing Operations

FederalIncomeTaxExpenseBenefitContinuingOperations

310000

usd

CY2016

us-gaap

State And Local Income Tax Expense Benefit Continuing Operations

StateAndLocalIncomeTaxExpenseBenefitContinuingOperations

usd

CY2015

us-gaap

State And Local Income Tax Expense Benefit Continuing Operations

StateAndLocalIncomeTaxExpenseBenefitContinuingOperations

29313

usd

CY2014

us-gaap

State And Local Income Tax Expense Benefit Continuing Operations

StateAndLocalIncomeTaxExpenseBenefitContinuingOperations

24093

usd

CY2015Q2

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts

6607107

usd

CY2016Q2

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts

6495094

usd

CY2015Q2

us-gaap

Accounts Payable And Accrued Liabilities Current

AccountsPayableAndAccruedLiabilitiesCurrent

115346

usd

CY2016Q2

us-gaap

Accounts Payable And Accrued Liabilities Current

AccountsPayableAndAccruedLiabilitiesCurrent

962867

usd

CY2015Q2

FONR

Tax Credit Carryforward

TaxCreditCarryforward

6751692

usd

CY2016Q2

FONR

Tax Credit Carryforward

TaxCreditCarryforward

6770099

usd

CY2015Q2

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

63849156

usd

CY2016Q2

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

58344864

usd

CY2015Q2

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

-55425850

usd

CY2016Q2

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

-45302504

usd

CY2015Q2

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

8423306

usd

CY2016Q2

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

13042360

usd

CY2015Q2

us-gaap

Capitalized Software Development Costs For Software Sold To Customers

CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers

-510492

usd

CY2016Q2

us-gaap

Capitalized Software Development Costs For Software Sold To Customers

CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers

-481779

usd

CY2015Q2

us-gaap

Deferred Tax Liabilities Gross Current

DeferredTaxLiabilitiesGrossCurrent

-510492

usd

CY2016Q2

us-gaap

Deferred Tax Liabilities Gross Current

DeferredTaxLiabilitiesGrossCurrent

-481779

usd

CY2015Q2

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

7912814

usd

CY2016Q2

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

12560581

usd

CY2015Q2

us-gaap

Accrued Salaries Current

AccruedSalariesCurrent

991603

usd

CY2016Q2

us-gaap

Accrued Salaries Current

AccruedSalariesCurrent

3188665

usd

CY2015Q2

us-gaap

Interest Receivable Current

InterestReceivableCurrent

117480

usd

CY2016Q2

us-gaap

Interest Receivable Current

InterestReceivableCurrent

45479

usd

CY2015Q2

us-gaap

Other Accrued Liabilities Current

OtherAccruedLiabilitiesCurrent

521149

usd

CY2016Q2

us-gaap

Other Accrued Liabilities Current

OtherAccruedLiabilitiesCurrent

545029

usd

CY2015Q2

us-gaap

Sales And Excise Tax Payable Current

SalesAndExciseTaxPayableCurrent

2538340

usd

CY2016Q2

us-gaap

Sales And Excise Tax Payable Current

SalesAndExciseTaxPayableCurrent

2402448

usd

CY2015Q2

us-gaap

Accrued Professional Fees Current

AccruedProfessionalFeesCurrent

344060

usd

CY2016Q2

us-gaap

Accrued Professional Fees Current

AccruedProfessionalFeesCurrent

384810

usd

CY2015Q2

us-gaap

Accrued Professional Fees Current And Noncurrent

AccruedProfessionalFeesCurrentAndNoncurrent

235000

usd

CY2016Q2

us-gaap

Accrued Professional Fees Current And Noncurrent

AccruedProfessionalFeesCurrentAndNoncurrent

241400

usd

CY2015Q2

us-gaap

Other Sundry Liabilities Current

OtherSundryLiabilitiesCurrent

486011

usd

CY2016Q2

us-gaap

Other Sundry Liabilities Current

OtherSundryLiabilitiesCurrent

1139857

usd

CY2016

us-gaap

Revenues

2140000

usd

CY2015

us-gaap

Revenues

2005000

usd

CY2014

us-gaap

Revenues

1963750

usd

CY2016

us-gaap

Income Loss From Continuing Operations

IncomeLossFromContinuingOperations

14355616

usd

CY2015

us-gaap

Income Loss From Continuing Operations

IncomeLossFromContinuingOperations

12899877

usd

CY2014

us-gaap

Income Loss From Continuing Operations

IncomeLossFromContinuingOperations

12302669

usd

CY2016

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

3297289

usd

CY2015

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

3544470

usd

CY2014

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

3817205

usd

CY2016

FONR

Compensatory Element Of Stock Issuances

CompensatoryElementOfStockIssuances

2006

usd

CY2015

FONR

Compensatory Element Of Stock Issuances

CompensatoryElementOfStockIssuances

53200

usd

CY2014

FONR

Compensatory Element Of Stock Issuances

CompensatoryElementOfStockIssuances

223000

usd

CY2016

FONR

Identifiable Assets

IdentifiableAssets

84887606

usd

CY2015

FONR

Identifiable Assets

IdentifiableAssets

76492077

usd

CY2014

FONR

Identifiable Assets

IdentifiableAssets

76789843

usd

CY2016

FONR

Capital Expenditures

CapitalExpenditures

825288

usd

CY2015

FONR

Capital Expenditures

CapitalExpenditures

270842

usd

CY2014

FONR

Capital Expenditures

CapitalExpenditures

834908

usd

CY2016

us-gaap

Sales Revenue Goods Net

SalesRevenueGoodsNet

1276882

usd

CY2015

us-gaap

Sales Revenue Goods Net

SalesRevenueGoodsNet

1820979

usd

CY2014

us-gaap

Sales Revenue Goods Net

SalesRevenueGoodsNet

1877932

usd

CY2016

us-gaap

Maintenance Revenue

MaintenanceRevenue

9396736

usd

CY2015

us-gaap

Maintenance Revenue

MaintenanceRevenue

9549316

usd

CY2014

us-gaap

Maintenance Revenue

MaintenanceRevenue

10082631

usd

CY2016

us-gaap

Health Care Organization Patient Service Revenue

HealthCareOrganizationPatientServiceRevenue

32985809

usd

CY2015

us-gaap

Health Care Organization Patient Service Revenue

HealthCareOrganizationPatientServiceRevenue

28153598

usd

CY2014

us-gaap

Health Care Organization Patient Service Revenue

HealthCareOrganizationPatientServiceRevenue

24307192

usd

CY2016

us-gaap

Management Fees Revenue

ManagementFeesRevenue

36633230

usd

CY2015

us-gaap

Management Fees Revenue

ManagementFeesRevenue

34805627

usd

CY2014

us-gaap

Management Fees Revenue

ManagementFeesRevenue

34839969

usd

CY2016

FONR

Management And Other Fees Related Medical Practices Net

ManagementAndOtherFeesRelatedMedicalPracticesNet

7505339

usd

CY2015

FONR

Management And Other Fees Related Medical Practices Net

ManagementAndOtherFeesRelatedMedicalPracticesNet

7381725

usd

CY2014

FONR

Management And Other Fees Related Medical Practices Net

ManagementAndOtherFeesRelatedMedicalPracticesNet

7620835

usd

CY2016

us-gaap

Cost Of Goods Sold

CostOfGoodsSold

1254328

usd

CY2015

us-gaap

Cost Of Goods Sold

CostOfGoodsSold

1882230

usd

CY2014

us-gaap

Cost Of Goods Sold

CostOfGoodsSold

1067120

usd

CY2016

us-gaap

Maintenance Costs

MaintenanceCosts

2148143

usd

CY2015

us-gaap

Maintenance Costs

MaintenanceCosts

2189373

usd

CY2014

us-gaap

Maintenance Costs

MaintenanceCosts

2496985

usd

CY2016

FONR

Costs Related To Service And Repair Fees Related Parties

CostsRelatedToServiceAndRepairFeesRelatedParties

25147

usd

CY2015

FONR

Costs Related To Service And Repair Fees Related Parties

CostsRelatedToServiceAndRepairFeesRelatedParties

25220

usd

CY2014

FONR

Costs Related To Service And Repair Fees Related Parties

CostsRelatedToServiceAndRepairFeesRelatedParties

27242

usd

CY2016

us-gaap

Service Management Costs

ServiceManagementCosts

21949583

usd

CY2015

us-gaap

Service Management Costs

ServiceManagementCosts

20970116

usd

CY2014

us-gaap

Service Management Costs

ServiceManagementCosts

20851065

usd

CY2016

FONR

Costs Related To Management And Other Fees Related Medical Practices

CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices

4074762

usd

CY2015

FONR

Costs Related To Management And Other Fees Related Medical Practices

CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices

3883953

usd

CY2014

FONR

Costs Related To Management And Other Fees Related Medical Practices

CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices

3744446

usd

CY2016

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

1631846

usd

CY2015

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

1812398

usd

CY2014

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

1760821

usd

CY2016

us-gaap

Selling General And Administrative Expense

SellingGeneralAndAdministrativeExpense

18509850

usd

CY2015

us-gaap

Selling General And Administrative Expense

SellingGeneralAndAdministrativeExpense

17448305

usd

CY2014

us-gaap

Selling General And Administrative Expense

SellingGeneralAndAdministrativeExpense

18584645

usd

CY2016

us-gaap

Provision For Doubtful Accounts

ProvisionForDoubtfulAccounts

-201949

usd

CY2015

us-gaap

Provision For Doubtful Accounts

ProvisionForDoubtfulAccounts

2475032

usd

CY2014

us-gaap

Provision For Doubtful Accounts

ProvisionForDoubtfulAccounts

1806299

usd

CY2016

us-gaap

Costs And Expenses

CostsAndExpenses

59012594

usd

CY2015

us-gaap

Costs And Expenses

CostsAndExpenses

56151119

usd

CY2014

us-gaap

Costs And Expenses

CostsAndExpenses

56202808

usd

CY2016

us-gaap

Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net

IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet

14355616

usd

CY2015

us-gaap

Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net

IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet

12899877

usd

CY2014

us-gaap

Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net

IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet

12302669

usd

CY2016

us-gaap

Interest Expense

InterestExpense

-262193

usd

CY2015

us-gaap

Interest Expense

InterestExpense

-702095

usd

CY2014

us-gaap

Interest Expense

InterestExpense

-884541

usd

CY2016

us-gaap

Investment Income Net

InvestmentIncomeNet

224263

usd

CY2015

us-gaap

Investment Income Net

InvestmentIncomeNet

225270

usd

CY2014

us-gaap

Investment Income Net

InvestmentIncomeNet

238928

usd

CY2016

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

14508246

usd

CY2015

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

12817862

usd

CY2016

us-gaap

Increase Decrease In Receivables

IncreaseDecreaseInReceivables

28280

usd

CY2015

us-gaap

Increase Decrease In Receivables

IncreaseDecreaseInReceivables

135592

usd

CY2014

us-gaap

Increase Decrease In Receivables

IncreaseDecreaseInReceivables

95623

usd

CY2016

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

16617369

usd

CY2015

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

13272917

usd

CY2014

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

11048457

usd

CY2016

us-gaap

Profit Loss

ProfitLoss

18795517

usd

CY2015

us-gaap

Profit Loss

ProfitLoss

15430383

usd

CY2014

us-gaap

Profit Loss

ProfitLoss

13396769

usd

CY2016

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

-3070892

usd

CY2015

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

-2519732

usd

CY2014

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

-3000639

usd

CY2016

us-gaap

Cost Of Property Repairs And Maintenance

CostOfPropertyRepairsAndMaintenance

1113000

usd

CY2015

us-gaap

Cost Of Property Repairs And Maintenance

CostOfPropertyRepairsAndMaintenance

1200000

usd

CY2014

us-gaap

Cost Of Property Repairs And Maintenance

CostOfPropertyRepairsAndMaintenance

1037000

usd

CY2016

us-gaap

Health Care Organization Patient Service Revenue Provisionfor Bad Debts

HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts

-14539786

usd

CY2015

us-gaap

Health Care Organization Patient Service Revenue Provisionfor Bad Debts

HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts

-12770249

usd

CY2014

us-gaap

Health Care Organization Patient Service Revenue Provisionfor Bad Debts

HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts

-10333082

usd

CY2016

us-gaap

Health Care Organization Patient Service Revenue Less Provision For Bad Debts

HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts

18446023

usd

CY2015

us-gaap

Health Care Organization Patient Service Revenue Less Provision For Bad Debts

HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts

15383349

usd

CY2014

us-gaap

Health Care Organization Patient Service Revenue Less Provision For Bad Debts

HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts

13974110

usd

CY2014

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

13390923

usd

CY2016

us-gaap

Revenue Recognition Allowances

RevenueRecognitionAllowances

Revenue Recognition   The Company’s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2016, 2015 and 2014 are summarized in the following table.   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid">For the Year Ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2016</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2014</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Commercial Insurance/ Managed Care</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,659,322</td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,398,589</td><td style="width: 1%; text-align: left"> </td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,217,088</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.1pt; padding-left: 8.1pt">Medicare/Medicaid</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,182,552</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,187,690</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,443,020</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Workers' Compensation/Personal Injury</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,888,856</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,978,243</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,369,956</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,255,079</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,589,076</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,277,128</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt">Patient Fee Revenue, net of contractual allowances and discounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32,985,809</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,153,598</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,307,192</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt">Provision for Bad Debts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(14,539,786</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(12,770,249</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,333,082</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt">Net Patient Fee Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18,446,023</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,383,349</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,974,110</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

CY2016

FONR

Export Product Sales

ExportProductSales

Export Product Sales   The foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries: <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 50%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: normal; font-style: normal"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="11" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">For the Years Ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: normal; font-style: normal"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">2016</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">2015</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">2014</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt">United Arab Emirates</td><td style="width: 5%; font-weight: normal; font-style: normal"> </td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">-%</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 5%; font-weight: normal; font-style: normal"> </td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">-%</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 5%; font-weight: normal; font-style: normal"> </td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">29.8</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Switzerland</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">2.2</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">12.4</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Canada</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">0.3</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">0.1</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">England</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">18.5</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Germany</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">.6</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">71.9</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt">Puerto Rico</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">.2</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; padding-left: 5.4pt">Libya</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">—  </td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">0.2</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; padding-left: 5.4pt"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">19.6</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">%</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">74.2</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">%</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">42.4</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">%</td></tr> </table>

CY2016

FONR

Export Service Revenues

ExportServiceRevenues

Foreign Service and Repair Fees   Foreign service and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries:   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 50%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: normal; font-style: normal"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="11" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">For the Years Ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: normal; font-style: normal"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">2016</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">2015</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">2014</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; font-weight: normal; font-style: normal; padding-left: 5.4pt">Spain</td><td style="width: 5%; font-weight: normal; font-style: normal"> </td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">0.3</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">%</td><td style="width: 5%; font-weight: normal; font-style: normal"> </td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">1.0</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">%</td><td style="width: 5%; font-weight: normal; font-style: normal"> </td> <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"> </td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">1.0</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt">Puerto Rico</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">1.5</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">1.2</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">1.1</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Switzerland</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">0.3</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">0.7</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">1.1</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Germany</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">1.5</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">0.7</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">0.4</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">England</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">0.5</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">1.7</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">2.6</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Holland</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">0.6</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">1.3</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Canada</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">0.3</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">0.1</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">0.2</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt">Greece</td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">0.2</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">0.2</td><td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal"> </td> <td style="font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; text-align: right">—  </td><td style="font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; padding-left: 5.4pt">Australia</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">1.2</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">1.2</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">1.1</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; padding-left: 5.4pt"> </td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">5.8</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">%</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">7.4</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">%</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">8.8</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">%</td></tr> </table>

CY2015Q2

us-gaap

Finite Lived Contractual Rights Gross

FiniteLivedContractualRightsGross

4100000

usd

CY2016Q2

us-gaap

Finite Lived Contractual Rights Gross

FiniteLivedContractualRightsGross

4100000

usd

CY2015Q2

FONR

Customer Relationships Intangible Asset

CustomerRelationshipsIntangibleAsset

3800000

usd

CY2016Q2

FONR

Customer Relationships Intangible Asset

CustomerRelationshipsIntangibleAsset

3800000

usd

CY2015Q2

FONR

Amoritization Of Other Intangible Assets

AmoritizationOfOtherIntangibleAssets

-1284628

usd

CY2014Q2

FONR

Amoritization Of Other Intangible Assets

AmoritizationOfOtherIntangibleAssets

-1359093

usd

CY2016Q2

FONR

Amoritization Of Other Intangible Assets

AmoritizationOfOtherIntangibleAssets

-1255078

usd

CY2015Q2

us-gaap

Goodwill

1767098

usd

CY2016Q2

us-gaap

Goodwill

3322158

usd

CY2015Q2

us-gaap

Deferred Income Taxes And Other Liabilities Noncurrent

DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent

510492

usd

CY2016Q2

us-gaap

Deferred Income Taxes And Other Liabilities Noncurrent

DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent

481779

usd

CY2016

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

usd

CY2015

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

usd

CY2014

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

-19501

usd

CY2016

us-gaap

Increase Decrease In Accounts Payable Related Parties

IncreaseDecreaseInAccountsPayableRelatedParties

8121

usd

CY2015

us-gaap

Increase Decrease In Accounts Payable Related Parties

IncreaseDecreaseInAccountsPayableRelatedParties

2339

usd

CY2014

us-gaap

Increase Decrease In Accounts Payable Related Parties

IncreaseDecreaseInAccountsPayableRelatedParties

3955

usd

CY2016

us-gaap

Increase Decrease In Customer Advances

IncreaseDecreaseInCustomerAdvances

-739074

usd

CY2015

us-gaap

Increase Decrease In Customer Advances

IncreaseDecreaseInCustomerAdvances

11000

usd

CY2014

us-gaap

Increase Decrease In Customer Advances

IncreaseDecreaseInCustomerAdvances

68943

usd

CY2016

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

-527957

usd

CY2015

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

-699555

usd

CY2014

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

-270482

usd

CY2016Q2

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Two

FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

1155571

usd

CY2016Q2

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Three

FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

988324

usd

CY2016Q2

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Four

FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

791112

usd

CY2016Q2

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Five

FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

393075

usd

CY2016Q2

us-gaap

Finite Lived Intangible Assets Amortization Expense After Year Five

FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive

3159015

usd

CY2015Q2

us-gaap

Long Term Debt And Capital Lease Obligations Current

LongTermDebtAndCapitalLeaseObligationsCurrent

2490146

usd

CY2016Q2

us-gaap

Long Term Debt And Capital Lease Obligations Current

LongTermDebtAndCapitalLeaseObligationsCurrent

2447693

usd

CY2015Q2

us-gaap

Long Term Debt And Capital Lease Obligations

LongTermDebtAndCapitalLeaseObligations

5699302

usd

CY2016Q2

us-gaap

Long Term Debt And Capital Lease Obligations

LongTermDebtAndCapitalLeaseObligations

2059236

usd

CY2016

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

-4287271

usd

CY2015

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

-2612521

usd

CY2014

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

-2348312

usd

CY2016

FONR

Foreign Product Sales

ForeignProductSales

0.196

pure

CY2015

FONR

Foreign Product Sales

ForeignProductSales

0.742

pure

CY2014

FONR

Foreign Product Sales

ForeignProductSales

0.424

pure

CY2016

FONR

Foreign Service And Repair Fees

ForeignServiceAndRepairFees

0.058

pure

CY2015

FONR

Foreign Service And Repair Fees

ForeignServiceAndRepairFees

0.074

pure

CY2014

FONR

Foreign Service And Repair Fees

ForeignServiceAndRepairFees

0.088

pure

CY2016

us-gaap

Advertising Expense

AdvertisingExpense

535000

usd

CY2015

us-gaap

Advertising Expense

AdvertisingExpense

894000

usd

CY2014

us-gaap

Advertising Expense

AdvertisingExpense

889000

usd

CY2016

us-gaap

Shipping Handling And Transportation Costs

ShippingHandlingAndTransportationCosts

11077

usd

CY2015

us-gaap

Shipping Handling And Transportation Costs

ShippingHandlingAndTransportationCosts

9293

usd

CY2014

us-gaap

Shipping Handling And Transportation Costs

ShippingHandlingAndTransportationCosts

1885

usd

CY2016Q2

us-gaap

Cash Fdic Insured Amount

CashFDICInsuredAmount

250000

usd

CY2016Q2

us-gaap

Cash

5804000

usd

CY2016

FONR

Net Revenues From Related Parties As Percentage Of Consolidated Net Revenues

NetRevenuesFromRelatedPartiesAsPercentageOfConsolidatedNetRevenues

0.1

pure

CY2015

FONR

Net Revenues From Related Parties As Percentage Of Consolidated Net Revenues

NetRevenuesFromRelatedPartiesAsPercentageOfConsolidatedNetRevenues

0.11

pure

CY2014

FONR

Net Revenues From Related Parties As Percentage Of Consolidated Net Revenues

NetRevenuesFromRelatedPartiesAsPercentageOfConsolidatedNetRevenues

0.11

pure

CY2002Q3

FONR

Fonar2002 Plan Permitted Issuances Of Stock Options

Fonar2002PlanPermittedIssuancesOfStockOptions

100000

shares

CY2016

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

35.00

pure

CY2015

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

35.00

pure

CY2014

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

34.00

pure

CY2016

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

6.00

pure

CY2015

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

6.00

pure

CY2014

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

6.00

pure

CY2016

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

0.20

pure

CY2015

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

0.20

pure

CY2014

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

0.90

pure

CY2016

us-gaap

Effective Income Tax Rate Reconciliation Other Reconciling Items Percent

EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent

89.80

pure

CY2015

us-gaap

Effective Income Tax Rate Reconciliation Other Reconciling Items Percent

EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent

-65.40

pure

CY2014

us-gaap

Effective Income Tax Rate Reconciliation Other Reconciling Items Percent

EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent

-65.50

pure

CY2016

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

-48.60

pure

CY2015

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

-27.40

pure

CY2014

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

-29.20

pure

CY2016

us-gaap

Other Depreciation And Amortization

OtherDepreciationAndAmortization

3297289

usd

CY2015

us-gaap

Other Depreciation And Amortization

OtherDepreciationAndAmortization

3544470

usd

CY2014

us-gaap

Other Depreciation And Amortization

OtherDepreciationAndAmortization

3817205

usd

CY2016

us-gaap

Acquired Finite Lived Intangible Assets Weighted Average Useful Life

AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife

P10Y256D

CY2016

us-gaap

Lease And Rental Expense

LeaseAndRentalExpense

4222000

usd

CY2015

us-gaap

Lease And Rental Expense

LeaseAndRentalExpense

4266000

usd

CY2014

us-gaap

Lease And Rental Expense

LeaseAndRentalExpense

4571000

usd

CY2016

us-gaap

Litigation Settlement Amount

LitigationSettlementAmount

usd

CY2015

us-gaap

Litigation Settlement Amount

LitigationSettlementAmount

usd

CY2014

us-gaap

Litigation Settlement Amount

LitigationSettlementAmount

13586

usd

CY2016

us-gaap

Increase Decrease In Accrued Taxes Payable

IncreaseDecreaseInAccruedTaxesPayable

2402000

usd

CY2016

FONR

Recorded Sales Tax Obligations Interest And Penalties

RecordedSalesTaxObligationsInterestAndPenalties

2487000

usd

CY2016

dei

Entity Registrant Name

EntityRegistrantName

Fonar Corporation

CY2016

dei

Entity Central Index Key

EntityCentralIndexKey

0000355019

CY2016

dei

Document Type

DocumentType

10-K

CY2016

dei

Document Period End Date

DocumentPeriodEndDate

2016-06-30

CY2016

dei

Amendment Flag

AmendmentFlag

false

CY2016

dei

Current Fiscal Year End Date

CurrentFiscalYearEndDate

--06-30

CY2016

dei

Entity Well Known Seasoned Issuer

EntityWellKnownSeasonedIssuer

No

CY2016

dei

Entity Voluntary Filers

EntityVoluntaryFilers

No

CY2016

dei

Entity Current Reporting Status

EntityCurrentReportingStatus

Yes

CY2016

dei

Entity Filer Category

EntityFilerCategory

Accelerated Filer

CY2016

dei

Document Fiscal Period Focus

DocumentFiscalPeriodFocus

FY

CY2016

dei

Document Fiscal Year Focus

DocumentFiscalYearFocus

2016

CY2015Q2

FONR

Net Operating Carryforwards

NetOperatingCarryforwards

49170420

usd

CY2016Q2

FONR

Net Operating Carryforwards

NetOperatingCarryforwards

44011554

usd

CY2016

us-gaap

Other Income

OtherIncome

-2439

usd

CY2015

us-gaap

Other Income

OtherIncome

13

usd

CY2014

us-gaap

Other Income

OtherIncome

-4835

usd

CY2016Q2

us-gaap

Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five

LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive

237656

usd

CY2016Q2

us-gaap

Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three

LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree

30746

usd

CY2016Q2

us-gaap

Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four

LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour

32944

usd

CY2016Q2

us-gaap

Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five

LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive

35416

usd

CY2016Q2

us-gaap

Long Term Debt And Capital Lease Obligations Including Current Maturities

LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities

4506929

usd

CY2015Q2

FONR

Managment And Other Fees Receivable Related Medical Practices Net Allowances

ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances

3507204

usd

CY2016Q2

FONR

Managment And Other Fees Receivable Related Medical Practices Net Allowances

ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances

4063539

usd

CY2016

FONR

Net Management Fee Receivables From Related Medical Practices Of Consolidated Accounts Receivable

NetManagementFeeReceivablesFromRelatedMedicalPracticesOfConsolidatedAccountsReceivable

0.12

pure

CY2015Q2

FONR

Accounts Receivable Service And Repair Fees

AccountsReceivableServiceAndRepairFees

3790981

usd

CY2016Q2

FONR

Accounts Receivable Service And Repair Fees

AccountsReceivableServiceAndRepairFees

4370155

usd

CY2015Q2

FONR

Medical Receivable

MedicalReceivable

9082319

usd

CY2016Q2

FONR

Medical Receivable

MedicalReceivable

10126397

usd

CY2015Q2

FONR

Management And Other Fees Non Related Parties

ManagementAndOtherFees_NonRelatedParties

14057962

usd

CY2016Q2

FONR

Management And Other Fees Non Related Parties

ManagementAndOtherFees_NonRelatedParties

15637831

usd

CY2015Q2

us-gaap

Shares Issued

SharesIssued

shares

CY2014Q2

us-gaap

Shares Issued

SharesIssued

shares

CY2013Q2

us-gaap

Shares Issued

SharesIssued

shares

CY2016Q2

us-gaap

Shares Issued

SharesIssued

shares

CY2016

us-gaap

Stock Issued During Period Shares Employee Benefit Plan

StockIssuedDuringPeriodSharesEmployeeBenefitPlan

shares

CY2015

us-gaap

Stock Issued During Period Shares Employee Benefit Plan

StockIssuedDuringPeriodSharesEmployeeBenefitPlan

shares

CY2014

us-gaap

Stock Issued During Period Shares Employee Benefit Plan

StockIssuedDuringPeriodSharesEmployeeBenefitPlan

shares

CY2016

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

shares

CY2015

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

shares

CY2014

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

shares

CY2016

us-gaap

Stock Issued During Period Value Stock Options Exercised

StockIssuedDuringPeriodValueStockOptionsExercised

1755

usd

CY2015

us-gaap

Stock Issued During Period Value Stock Options Exercised

StockIssuedDuringPeriodValueStockOptionsExercised

usd

CY2014

us-gaap

Stock Issued During Period Value Stock Options Exercised

StockIssuedDuringPeriodValueStockOptionsExercised

30600

usd

CY2015Q2

us-gaap

Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year

CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear

1861350

usd

CY2016Q2

us-gaap

Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year

CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear

893976

usd

CY2015Q2

FONR

Estimated Earnings

EstimatedEarnings

1371093

usd

CY2016Q2

FONR

Estimated Earnings

EstimatedEarnings

491476

usd

CY2016

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

shares

CY2015

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

shares

CY2014

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

6610

shares

CY2015Q2

us-gaap

Customer Advances Current

CustomerAdvancesCurrent

1937813

usd

CY2016Q2

us-gaap

Customer Advances Current

CustomerAdvancesCurrent

1198739

usd

CY2010Q3

FONR

Shares Registered Under Form S8

SharesRegisteredUnderFormS8

2000000

shares

CY2011Q2

FONR

Private Placement Of Equity

PrivatePlacementOfEquity

6000000

usd

CY2011Q2

us-gaap

Preferred Stock Redemption Amount

PreferredStockRedemptionAmount

1125100

usd

CY2014Q2

us-gaap

Preferred Stock Redemption Amount

PreferredStockRedemptionAmount

1125100

usd

CY2015Q2

us-gaap

Preferred Stock Redemption Amount

PreferredStockRedemptionAmount

1125100

usd

CY2016

us-gaap

Multiemployer Plan Period Contributions

MultiemployerPlanPeriodContributions

0

usd

CY2015

us-gaap

Multiemployer Plan Period Contributions

MultiemployerPlanPeriodContributions

0

usd

CY2014

us-gaap

Multiemployer Plan Period Contributions

MultiemployerPlanPeriodContributions

0

usd

CY2016

FONR

Average Monthly Payment For Stipulation Agreements

AverageMonthlyPaymentForStipulationAgreements

15859

usd

CY2015Q2

us-gaap

Liability For Claims And Claims Adjustment Expense Disability Accident And Health

LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth

510000

usd

CY2016Q2

us-gaap

Liability For Claims And Claims Adjustment Expense Disability Accident And Health

LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth

392000

usd

CY2016

FONR

Stoploss Umbrella Policy With3 Rd Paryinsurer To Limit Maximum Potential Liability For Individual Claims

StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims

100000

usd

CY2015Q2

us-gaap

Notes Receivable Fair Value Disclosure

NotesReceivableFairValueDisclosure

-31495

usd

CY2015

FONR

Net Management Fee Receivables From Related Medical Practices Of Consolidated Accounts Receivable

NetManagementFeeReceivablesFromRelatedMedicalPracticesOfConsolidatedAccountsReceivable

0.12

pure

CY2014

FONR

Net Management Fee Receivables From Related Medical Practices Of Consolidated Accounts Receivable

NetManagementFeeReceivablesFromRelatedMedicalPracticesOfConsolidatedAccountsReceivable

0.12

pure

CY2010Q2

FONR

Shares Reserved For2010 Stock Bonus Plan

SharesReservedFor2010StockBonusPlan

2000000

shares

CY2015Q2

us-gaap

Deferred Tax Assets Deferred Income

DeferredTaxAssetsDeferredIncome

8423306

usd

CY2016Q2

us-gaap

Deferred Tax Assets Deferred Income

DeferredTaxAssetsDeferredIncome

13042360

usd

CY2015Q2

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

8950160

usd

CY2016Q2

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

7719358

usd

CY2015Q2

us-gaap

Accounts Payable Related Parties Noncurrent

AccountsPayableRelatedPartiesNoncurrent

236920

usd

CY2016Q2

us-gaap

Accounts Payable Related Parties Noncurrent

AccountsPayableRelatedPartiesNoncurrent

245041

usd

CY2016Q2

us-gaap

Notes Receivable Fair Value Disclosure

NotesReceivableFairValueDisclosure

-23879

usd

CY2015Q2

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1

50783513

usd

CY2016Q2

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1

60776307

usd

CY2016

FONR

Service And Repair Fees Related Parties Net

ServiceAndRepairFeesRelatedPartiesNet

110000

usd

CY2015

FONR

Service And Repair Fees Related Parties Net

ServiceAndRepairFeesRelatedPartiesNet

110000

usd

CY2014

FONR

Service And Repair Fees Related Parties Net

ServiceAndRepairFeesRelatedPartiesNet

110000

usd

CY2016

us-gaap

Other Cost Of Operating Revenue

OtherCostOfOperatingRevenue

9418935

usd

CY2015

us-gaap

Other Cost Of Operating Revenue

OtherCostOfOperatingRevenue

7939524

usd

CY2014

us-gaap

Other Cost Of Operating Revenue

OtherCostOfOperatingRevenue

7670484

usd

CY2016

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

190560

usd

CY2015

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

394810

usd

CY2014

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

-608599

usd

CY2015Q2

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

9448798

usd

CY2014Q2

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

9951736

usd

CY2013Q2

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

7870727

usd

CY2016Q2

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

8528309

usd

CY2015Q2

us-gaap

Stockholders Equity Attributable To Parent Not Allowable For Net Capital

StockholdersEquityAttributableToParentNotAllowableForNetCapital

38392742

usd

CY2016Q2

us-gaap

Stockholders Equity Attributable To Parent Not Allowable For Net Capital

StockholdersEquityAttributableToParentNotAllowableForNetCapital

52379732

usd

CY2016

us-gaap

Incremental Common Shares Attributable To Call Options And Warrants

IncrementalCommonSharesAttributableToCallOptionsAndWarrants

1755

shares

CY2015

us-gaap

Incremental Common Shares Attributable To Call Options And Warrants

IncrementalCommonSharesAttributableToCallOptionsAndWarrants

shares

CY2014

us-gaap

Incremental Common Shares Attributable To Call Options And Warrants

IncrementalCommonSharesAttributableToCallOptionsAndWarrants

30600

shares

CY2016

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-4647767

usd

CY2015

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-2756517

usd

CY2014

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-2682405

usd

CY2016

FONR

Provision For Bad Debts

ProvisionForBadDebts

-201949

usd

CY2015

FONR

Provision For Bad Debts

ProvisionForBadDebts

2475032

usd

CY2014

FONR

Provision For Bad Debts

ProvisionForBadDebts

1806299

usd

CY2016

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

usd

CY2015

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-394797

usd

CY2014

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

usd

CY2016Q2

us-gaap

Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months

LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths

2447693

usd

CY2016

FONR

Payments On Notes Receivable From Employee Stockholders

PaymentsOnNotesReceivableFromEmployeeStockholders

7616

usd

CY2015

FONR

Payments On Notes Receivable From Employee Stockholders

PaymentsOnNotesReceivableFromEmployeeStockholders

7333

usd

CY2014

FONR

Payments On Notes Receivable From Employee Stockholders

PaymentsOnNotesReceivableFromEmployeeStockholders

15992

usd

CY2016

FONR

Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims

PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims

.59

pure

CY2015

FONR

Percentage Of Consolidated Net Revenue From Management Fees

PercentageOfConsolidatedNetRevenueFromManagementFees

0.11

pure

CY2014

FONR

Percentage Of Consolidated Net Revenue From Management Fees

PercentageOfConsolidatedNetRevenueFromManagementFees

0.11

pure

CY2015

FONR

Export Sales Of Medical Equipment

ExportSalesOfMedicalEquipment

.742

pure

CY2014

FONR

Export Sales Of Medical Equipment

ExportSalesOfMedicalEquipment

.424

pure

CY2016

FONR

Foreign Revenues Of Service And Repair Of Medical Equipment

ForeignRevenuesOfServiceAndRepairOfMedicalEquipment

.058

pure

CY2015

FONR

Foreign Revenues Of Service And Repair Of Medical Equipment

ForeignRevenuesOfServiceAndRepairOfMedicalEquipment

.074

pure

CY2015

FONR

Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims

PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims

0.54

pure

CY2014

FONR

Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims

PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims

0.5

pure

CY2016

FONR

Percentage Of Consolidated Net Revenue From Management Fees

PercentageOfConsolidatedNetRevenueFromManagementFees

.1

pure

FONR

Property Tax Abatement From Suffolk County Ida

PropertyTaxAbatementFromSuffolkCountyIda

0.5

pure

FONR

Property Tax Abatement

PropertyTaxAbatement

440000

usd

CY2016

FONR

Included In Companys Accrued Expenses As Result Of Lawsuit

IncludedInCompanysAccruedExpensesAsResultOfLawsuit

300000

usd

CY2015

FONR

Included In Companys Accrued Expenses As Result Of Lawsuit

IncludedInCompanysAccruedExpensesAsResultOfLawsuit

300000

usd

CY2016

us-gaap

Interest Paid

InterestPaid

356106

usd

CY2015

us-gaap

Interest Paid

InterestPaid

516385

usd

CY2014

us-gaap

Interest Paid

InterestPaid

668475

usd

CY2016

us-gaap

Income Taxes Paid

IncomeTaxesPaid

360496

usd

CY2015

us-gaap

Income Taxes Paid

IncomeTaxesPaid

143996

usd

CY2014

us-gaap

Income Taxes Paid

IncomeTaxesPaid

349501

usd

CY2016

FONR

Export Sales Of Medical Equipment

ExportSalesOfMedicalEquipment

.196

pure

CY2014

FONR

Foreign Revenues Of Service And Repair Of Medical Equipment

ForeignRevenuesOfServiceAndRepairOfMedicalEquipment

0.088

pure

CY2016

FONR

Distributions To Noncontrolling Interests

DistributionsToNoncontrollingInterests

-2905000

usd

CY2015

FONR

Distributions To Noncontrolling Interests

DistributionsToNoncontrollingInterests

-1125000

usd

CY2014

FONR

Distributions To Noncontrolling Interests

DistributionsToNoncontrollingInterests

-1125100

usd

CY2016

us-gaap

Payments For Repurchase Of Redeemable Noncontrolling Interest

PaymentsForRepurchaseOfRedeemableNoncontrollingInterest

-2905000

usd

CY2015

us-gaap

Payments For Repurchase Of Redeemable Noncontrolling Interest

PaymentsForRepurchaseOfRedeemableNoncontrollingInterest

-1125000

usd

CY2014

us-gaap

Payments For Repurchase Of Redeemable Noncontrolling Interest

PaymentsForRepurchaseOfRedeemableNoncontrollingInterest

-1125100

usd

CY2016

us-gaap

Stock Issued During Period Value Share Based Compensation

StockIssuedDuringPeriodValueShareBasedCompensation

usd

CY2015

us-gaap

Stock Issued During Period Value Share Based Compensation

StockIssuedDuringPeriodValueShareBasedCompensation

109950

usd

CY2014

us-gaap

Stock Issued During Period Value Share Based Compensation

StockIssuedDuringPeriodValueShareBasedCompensation

531825

usd

CY2016

us-gaap

Stock Issued During Period Shares Share Based Compensation

StockIssuedDuringPeriodSharesShareBasedCompensation

shares

CY2015

us-gaap

Stock Issued During Period Shares Share Based Compensation

StockIssuedDuringPeriodSharesShareBasedCompensation

shares

CY2014

us-gaap

Stock Issued During Period Shares Share Based Compensation

StockIssuedDuringPeriodSharesShareBasedCompensation

shares

CY2016

us-gaap

Payments To Acquire Businesses Gross

PaymentsToAcquireBusinessesGross

-4223567

usd

CY2015

us-gaap

Payments To Acquire Businesses Gross

PaymentsToAcquireBusinessesGross

usd

CY2014

us-gaap

Payments To Acquire Businesses Gross

PaymentsToAcquireBusinessesGross

usd

CY2016

us-gaap

Issuance Of Stock And Warrants For Services Or Claims

IssuanceOfStockAndWarrantsForServicesOrClaims

usd

CY2015

us-gaap

Issuance Of Stock And Warrants For Services Or Claims

IssuanceOfStockAndWarrantsForServicesOrClaims

109950

usd

CY2014

us-gaap

Issuance Of Stock And Warrants For Services Or Claims

IssuanceOfStockAndWarrantsForServicesOrClaims

531825

usd

CY2016Q2

us-gaap

Finite Lived Intangible Assets Amortization Expense Next Twelve Months

FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

1232261

usd

CY2016

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

-278866

usd

CY2015

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

-403393

usd

CY2014

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

-402361

usd

CY2016

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-4368901

usd

CY2015

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-2353124

usd

CY2014

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-2280044

usd

CY2016

FONR

True Ups

TrueUps

pure

CY2015

FONR

True Ups

TrueUps

-3.20

pure

CY2014

FONR

True Ups

TrueUps

-2.80

pure

CY2015Q2

us-gaap

Other Accrued Liabilities Noncurrent

OtherAccruedLiabilitiesNoncurrent

2508840

usd

CY2016Q2

us-gaap

Other Accrued Liabilities Noncurrent

OtherAccruedLiabilitiesNoncurrent

2486927

usd

CY2015Q2

us-gaap

Self Insurance Reserve

SelfInsuranceReserve

510150

usd

CY2016Q2

us-gaap

Self Insurance Reserve

SelfInsuranceReserve

392178

usd

CY2016

us-gaap

Gain Loss On Disposition Of Assets1

GainLossOnDispositionOfAssets1

usd

CY2015

us-gaap

Gain Loss On Disposition Of Assets1

GainLossOnDispositionOfAssets1

usd

CY2014

us-gaap

Gain Loss On Disposition Of Assets1

GainLossOnDispositionOfAssets1

657350

usd

CY2016

us-gaap

Minority Interest Decrease From Distributions To Noncontrolling Interest Holders

MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

-5909100

usd

CY2015

us-gaap

Minority Interest Decrease From Distributions To Noncontrolling Interest Holders

MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

-4627851

usd

CY2014

us-gaap

Minority Interest Decrease From Distributions To Noncontrolling Interest Holders

MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

-4965770

usd

CY2016

FONR

Proceeds From Noncontrolling Interests

ProceedsFromNoncontrollingInterests

usd

CY2014

FONR

Proceeds From Noncontrolling Interests

ProceedsFromNoncontrollingInterests

usd

CY2016

FONR

Buyout Of Noncontrolling Interests

BuyoutOfNoncontrollingInterests

usd

CY2015

FONR

Buyout Of Noncontrolling Interests

BuyoutOfNoncontrollingInterests

-4971094

usd

CY2014

FONR

Buyout Of Noncontrolling Interests

BuyoutOfNoncontrollingInterests

usd

CY2016

FONR

Purchase Of Non Controlling Interest

PurchaseOfNonControllingInterest

usd

CY2015

FONR

Purchase Of Non Controlling Interest

PurchaseOfNonControllingInterest

-4971094

usd

CY2014

FONR

Purchase Of Non Controlling Interest

PurchaseOfNonControllingInterest

usd

CY2016

FONR

Billings In Excess Of Costs And Estimated Earnings On Uncompleted Contracts

BillingsInExcessOfCostsAndEstimatedEarningsOnUncompletedContracts

64406

usd

CY2015

FONR

Billings In Excess Of Costs And Estimated Earnings On Uncompleted Contracts

BillingsInExcessOfCostsAndEstimatedEarningsOnUncompletedContracts

usd

CY2014

FONR

Billings In Excess Of Costs And Estimated Earnings On Uncompleted Contracts

BillingsInExcessOfCostsAndEstimatedEarningsOnUncompletedContracts

usd

CY2016

us-gaap

Increase Decrease In Accrued Liabilities

IncreaseDecreaseInAccruedLiabilities

242798

usd

CY2015

us-gaap

Increase Decrease In Accrued Liabilities

IncreaseDecreaseInAccruedLiabilities

-190561

usd

CY2014

us-gaap

Increase Decrease In Accrued Liabilities

IncreaseDecreaseInAccruedLiabilities

-268261

usd

CY2015Q2

us-gaap

Billings In Excess Of Cost Current

BillingsInExcessOfCostCurrent

142217

usd

CY2016Q2

us-gaap

Billings In Excess Of Cost Current

BillingsInExcessOfCostCurrent

206623

usd

CY2016

us-gaap

Increase Decrease In Other Current Liabilities

IncreaseDecreaseInOtherCurrentLiabilities

3065673

usd

CY2015

us-gaap

Increase Decrease In Other Current Liabilities

IncreaseDecreaseInOtherCurrentLiabilities

-1041214

usd

CY2014

us-gaap

Increase Decrease In Other Current Liabilities

IncreaseDecreaseInOtherCurrentLiabilities

295219

usd

CY2016

FONR

Total Facilities Owned Or Managed At Beginning Of Year

TotalFacilitiesOwnedOrManagedAtBeginningOfYear

24

CY2015

FONR

Total Facilities Owned Or Managed At Beginning Of Year

TotalFacilitiesOwnedOrManagedAtBeginningOfYear

24

CY2014

FONR

Total Facilities Owned Or Managed At Beginning Of Year

TotalFacilitiesOwnedOrManagedAtBeginningOfYear

24

CY2016

FONR

Managed Facilities Added Acquisition

ManagedFacilitiesAddedAcquisition

1

CY2015

FONR

Managed Facilities Added Acquisition

ManagedFacilitiesAddedAcquisition

0

CY2014

FONR

Managed Facilities Added Acquisition

ManagedFacilitiesAddedAcquisition

0

CY2016

FONR

Managed Facilities Added By Internal Development

ManagedFacilitiesAddedByInternalDevelopment

0

CY2015

FONR

Managed Facilities Added By Internal Development

ManagedFacilitiesAddedByInternalDevelopment

0

CY2014

FONR

Managed Facilities Added By Internal Development

ManagedFacilitiesAddedByInternalDevelopment

1

CY2016

FONR

Total Facilities Owned Or Managed At End Of Year

TotalFacilitiesOwnedOrManagedAtEndOfYear

25

CY2015

FONR

Total Facilities Owned Or Managed At End Of Year

TotalFacilitiesOwnedOrManagedAtEndOfYear

24

CY2014

FONR

Total Facilities Owned Or Managed At End Of Year

TotalFacilitiesOwnedOrManagedAtEndOfYear

24

CY2016

FONR

Managed Facilities Closed During Year

ManagedFacilitiesClosedDuringYear

0

CY2015

FONR

Managed Facilities Closed During Year

ManagedFacilitiesClosedDuringYear

0

CY2014

FONR

Managed Facilities Closed During Year

ManagedFacilitiesClosedDuringYear

-1

CY2016

FONR

Gain On Sale Of Equipment

GainOnSaleOfEquipment

usd

CY2015

FONR

Gain On Sale Of Equipment

GainOnSaleOfEquipment

usd

CY2014

FONR

Gain On Sale Of Equipment

GainOnSaleOfEquipment

40000

usd

CY2016

us-gaap

Gain Loss On Disposition Of Assets

GainLossOnDispositionOfAssets

usd

CY2015

us-gaap

Gain Loss On Disposition Of Assets

GainLossOnDispositionOfAssets

usd

CY2014

us-gaap

Gain Loss On Disposition Of Assets

GainLossOnDispositionOfAssets

-657350

usd

CY2015Q2

us-gaap

Other Liabilities

OtherLiabilities

469198

usd

CY2016Q2

us-gaap

Other Liabilities

OtherLiabilities

711996

usd

CY2016

FONR

Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders

NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders

127504

shares

CY2015

FONR

Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders

NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders

127504

shares

CY2014

FONR

Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders

NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders

127504

shares

CY2013Q1

FONR

Health Diagnostics Management Hdm Class Outside Investors Members Contribution

HealthDiagnosticsManagementHdmClassOutsideInvestorsMembersContribution

19800000

usd

CY2013Q1

FONR

Health Diagnostics Management Hdm Class B Company Members Contribution

HealthDiagnosticsManagementHdmClassBCompanyMembersContribution

20200000

usd

CY2015Q3

FONR

Ownership Interest After Reorganization For Health Management Corporation Of America Of Newly Expanded Hdm Percent

OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent

0.458

pure

CY2015Q3

FONR

Ownership Interest After Reorganization For Hdm Original Investors Of Newly Expanded Hdm Percent

OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent

0.3

pure

CY2015Q3

FONR

Hmca Ownership Size Of Imperial Management Services Percent

HmcaOwnershipSizeOfImperialManagementServicesPercent

.242

pure

CY2016Q2

FONR

Purchase Of Equity In Turnkey Services Of New York Llc

PurchaseOfEquityInTurnkeyServicesOfNewYorkLlc

1

pure

CY2016Q2

FONR

Purchase Of Equity In Tk2 Equipment Management Llc

PurchaseOfEquityInTk2EquipmentManagementLlc

1

pure

CY2015Q2

FONR

Number Of Diagnostic Imaging Facilities Managed By Imperial

NumberOfDiagnosticImagingFacilitiesManagedByImperial

11

pure

CY2011Q2

FONR

Contribution By Hmca Of All Its Assets And Liabilities To Imperial Management Services Llc Imperial

ContributionByHmcaOfAllItsAssetsAndLiabilitiesToImperialManagementServicesLlcImperial

1

pure

CY2016Q2

FONR

Scanners With Management Agreements With Company Owned By Related Party

ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty

3

pure

CY2016Q2

FONR

Scanners With Management With Company Located In New York State

ScannersWithManagementWithCompanyLocatedInNewYorkState

18

pure

CY2016Q2

us-gaap

Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two

LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo

1722474

usd

CY2016

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

-192999

usd

CY2015

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

usd

CY2014

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

usd

CY2015Q2

us-gaap

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

18758344

usd

CY2016Q2

us-gaap

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

20800555

usd

CY2015Q2

FONR

Cost And Accumulated Depreciation Basis Of Retired Assets That Were Fully Depreciated

CostAndAccumulatedDepreciationBasisOfRetiredAssetsThatWereFullyDepreciated

1151541

usd

CY2015Q2

FONR

Shares Issued Under2010 Stock Bonus Plan

SharesIssuedUnder2010StockBonusPlan

5000

shares

CY2014Q2

FONR

Shares Issued Under2010 Stock Bonus Plan

SharesIssuedUnder2010StockBonusPlan

46708

shares

CY2016Q2

FONR

Shares Issued Under2010 Stock Bonus Plan

SharesIssuedUnder2010StockBonusPlan

146

shares

CY2014Q2

FONR

Stock Options Expired Under2002 Stock Option Plan

StockOptionsExpiredUnder2002StockOptionPlan

6610

shares

CY2014Q2

FONR

Options Outstanding Under2002 Stock Option Plan

OptionsOutstandingUnder2002StockOptionPlan

0

shares

CY2016Q2

us-gaap

Operating Leases Future Minimum Payments Due

OperatingLeasesFutureMinimumPaymentsDue

20600351

usd

CY2016Q2

us-gaap

Operating Leases Future Minimum Payments Due Thereafter

OperatingLeasesFutureMinimumPaymentsDueThereafter

6733116

usd

CY2016Q2

us-gaap

Operating Leases Future Minimum Payments Due In Five Years

OperatingLeasesFutureMinimumPaymentsDueInFiveYears

1848522

usd

CY2016Q2

us-gaap

Operating Leases Future Minimum Payments Due In Four Years

OperatingLeasesFutureMinimumPaymentsDueInFourYears

2178791

usd

CY2016Q2

us-gaap

Operating Leases Future Minimum Payments Due In Three Years

OperatingLeasesFutureMinimumPaymentsDueInThreeYears

2704324

usd

CY2016Q2

us-gaap

Operating Leases Future Minimum Payments Due In Two Years

OperatingLeasesFutureMinimumPaymentsDueInTwoYears

3295963

usd

CY2016Q2

us-gaap

Operating Leases Future Minimum Payments Due Current

OperatingLeasesFutureMinimumPaymentsDueCurrent

3839635

usd

CY2013Q1

FONR

Controlling Interest Acquired By Company Of Health Diagnostics Management Llc Hdm

ControllingInterestAcquiredByCompanyOfHealthDiagnosticsManagementLlcHdm

0.505

pure

CY2016Q2

us-gaap

Deferred Tax Assets Liabilities Net Current

DeferredTaxAssetsLiabilitiesNetCurrent

13042360

usd

CY2016Q2

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

481779

usd

CY2016Q2

us-gaap

Operating Loss Carryforwards

OperatingLossCarryforwards

110029000

usd

CY2016Q2

us-gaap

Deferred Tax Assets Tax Credit Carryforwards Research

DeferredTaxAssetsTaxCreditCarryforwardsResearch

4528000

usd

CY2016Q2

us-gaap

Tax Credit Carryforward Amount

TaxCreditCarryforwardAmount

1112000

usd

CY2015Q2

us-gaap

Deferred Income Tax Assets Net

DeferredIncomeTaxAssetsNet

6730000

usd

CY2016Q2

us-gaap

Deferred Income Tax Assets Net

DeferredIncomeTaxAssetsNet

10123000

usd

CY2016

FONR

Stipulation Agreement With Creditors

StipulationAgreementWithCreditors

297339

usd

CY2016

FONR

Estimated Useful Life In Years For Property And Equipment

EstimatedUsefulLifeInYearsForPropertyAndEquipment

Property and Equipment   The estimated useful lives in years are generally as follows:   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%; font: 10pt Arial, Helvetica, Sans-Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: justify; padding-left: 5.4pt">Diagnostic equipment under capital lease</td><td style="width: 4%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">2.5</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt">Diagnostic equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5–13</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">Research, development and demonstration equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3-7</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2-7</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3-9</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2–10</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">Building</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28</td><td style="text-align: left"> </td></tr> </table>

CY2016Q2

FONR

Common Stock Available Under Stock Bonus Plan

CommonStockAvailableUnderStockBonusPlan

953367

shares

CY2015Q2

us-gaap

Deferred Tax Assets Property Plant And Equipment

DeferredTaxAssetsPropertyPlantAndEquipment

1093401

usd

CY2016Q2

us-gaap

Deferred Tax Assets Property Plant And Equipment

DeferredTaxAssetsPropertyPlantAndEquipment

usd

CY2015Q2

us-gaap

Unbilled Contracts Receivable

UnbilledContractsReceivable

2693000

usd

CY2016Q2

us-gaap

Unbilled Contracts Receivable

UnbilledContractsReceivable

1592075

usd

CY2015Q2

us-gaap

Billed Contract Receivables

BilledContractReceivables

3232443

usd

CY2016Q2

us-gaap

Billed Contract Receivables

BilledContractReceivables

1385452

usd

CY2015Q2

FONR

Uncompleted Contracts

UncompletedContracts

539443

usd

CY2016Q2

FONR

Uncompleted Contracts

UncompletedContracts

-206623

usd

CY2015Q2

us-gaap

Deferred Tax Assets Inventory

DeferredTaxAssetsInventory

111190

usd

CY2016Q2

us-gaap

Deferred Tax Assets Inventory

DeferredTaxAssetsInventory

105250

usd

CY2016Q2

FONR

Purchase Amount By Company For Turnkey Services Of New York Llc.And Tk2 Equipment Llc.

PurchaseAmountByCompanyForTurnkeyServicesOfNewYorkLlc.AndTk2EquipmentLlc.

4223567

usd

CY2016Q2

FONR

Net Assets Attributed To Turnkey Services Of New York Llc.And Tk2 Equipment Llc.

NetAssetsAttributedToTurnkeyServicesOfNewYorkLlc.AndTk2EquipmentLlc.

2861506

usd

CY2015Q3

FONR

Contribution Percent Of Its Assets By Imperial Which Were Utilized In Business Of Health Management Corporation Of America To Hdm

ContributionPercentOfItsAssetsByImperialWhichWereUtilizedInBusinessOfHealthManagementCorporationOfAmericaToHdm

1

pure

CY2005Q1

FONR

Fonar2005 Plan Permitted Issuances Of Stock Options

Fonar2005PlanPermittedIssuancesOfStockOptions

80000

shares

CY2011Q2

FONR

Hmca Ownership Percentage Of Imperial

HmcaOwnershipPercentageOfImperial

0.75

pure

CY2016Q2

FONR

Hmca Ownership Percentage Of Imperial

HmcaOwnershipPercentageOfImperial

1

pure

CY2016Q2

FONR

Company Purchased Remaining Balance In Management Service Company In New York Metropolitan Area

CompanyPurchasedRemainingBalanceInManagementServiceCompanyInNewYorkMetropolitanArea

1780000

usd

CY2016Q2

us-gaap

Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax

DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax

1118000

usd

CY2016Q2

us-gaap

Deferred Taxes Business Combination Valuation Allowance Allocated To Contributed Capital

DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital

4600000

usd

CY2016Q3

FONR

Shares Of Common Stock To Employees And Consultants In Settlement Of Accrued Compensation Shares.

SharesOfCommonStockToEmployeesAndConsultantsInSettlementOfAccruedCompensationShares.

106600

shares

CY2016

us-gaap

Revenue Recognition Deferred Revenue

RevenueRecognitionDeferredRevenue

Customer Advances   Cash advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition occurs.

CY2015Q4

dei

Entity Public Float

EntityPublicFloat

104000000

usd

CY2016Q3

FONR

Value Of Shares Issued In Settlement Of Liabilities Value

ValueOfSharesIssuedInSettlementOfLiabilitiesValue

2000000

usd

CY2016Q2

FONR

Management Agreements With Company Total Medical Practices

ManagementAgreementsWithCompanyTotalMedicalPractices

21

pure

Name	View Source	Status
0000355019-16-000059-index-headers.html	Edgar Link	pending
0000355019-16-000059-index.html	Edgar Link	pending
0000355019-16-000059.txt	Edgar Link	pending
0000355019-16-000059-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fonar_exhibit-21.htm	Edgar Link	pending
fonar_exhibit-23.htm	Edgar Link	pending
fonar_exhibit-31.htm	Edgar Link	pending
fonar_exhibit-32.htm	Edgar Link	pending
fonar_form10-k.htm	Edgar Link	pending
fonr-20160630.xsd	Edgar Link	pending
image_001.gif	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
fonr-20160630_cal.xml	Edgar Link	unprocessable
fonr-20160630_def.xml	Edgar Link	unprocessable
fonr-20160630_lab.xml	Edgar Link	unprocessable
fonr-20160630_pre.xml	Edgar Link	unprocessable
fonr-20160630.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FONR
FONAR CORP Stock $fonr

2016 Form 10-K Financial Statement

#000035501916000059 Filed on September 28, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FONR FONAR CORP Stock $fonr

2016 Form 10-K Financial Statement

#000035501916000059 Filed on September 28, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FONR
FONAR CORP Stock $fonr